<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="http://onlinelibrarystatic.wiley.com/xslt/wol-journal-rss.xsl"
            type="text/xsl"?><rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"><channel rdf:about="http://onlinelibrary.wiley.com/rss/journal/10.1002/(ISSN)1365-2168" xmlns="http://purl.org/rss/1.0/"><title>British Journal of Surgery</title><description> Wiley Online Library : British Journal of Surgery</description><link>http://dx.doi.org/10.1002%2F%28ISSN%291365-2168</link><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc</dc:publisher><dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">en</dc:language><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</dc:rights><prism:issn xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">0007-1323</prism:issn><prism:eIssn xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">1365-2168</prism:eIssn><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">March 2012</prism:coverDisplayDate><prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">99</prism:volume><prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">3</prism:number><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">305</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">447</prism:endingPage><image rdf:resource="http://onlinelibrary.wiley.com/store/10.1002/bjs.v99.3/asset/cover.gif?v=1&amp;s=f00e1aec1c58ef07e9ccf26f60489de3aaeb972c"/><items><rdf:Seq><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.8691"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.8686"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.8695"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.8692"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.8697"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.8693"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.8688"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.8684"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.7819"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.8679"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.8660"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.7798"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.8689"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.8667"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.8665"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.8677"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.7823"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.7796"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.8654"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.8656"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.7822"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.7763"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.7744"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.7706"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.7813"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.7818"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.7734"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.7836"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.7803"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.8657"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.8655"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.7799"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.7762"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.7774"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.7765"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.7768"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.7738"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.7824"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.8659"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.8666"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.8658"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.7812"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.8664"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.7821"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.7837"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.7817"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.7814"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.7832"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.7816"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.7815"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.8680"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.8681"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.8682"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.8683"/><rdf:li rdf:resource="http://dx.doi.org/10.1002%2Fbjs.8694"/></rdf:Seq></items></channel><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.8691" xmlns="http://purl.org/rss/1.0/"><title>Risk of anastomotic leakage with non-steroidal anti-inflammatory drugs in colorectal surgery</title><link>http://dx.doi.org/10.1002%2Fbjs.8691</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Risk of anastomotic leakage with non-steroidal anti-inflammatory drugs in colorectal surgery</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">K. J. Gorissen</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">D. Benning</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">T. Berghmans</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. G. Snoeijs</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. N. Sosef</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">K. W. E. Hulsewe</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. D. P. Luyer</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-09T05:10:30.046265-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.8691</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.8691</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.8691</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>With the implementation of multimodal analgesia regimens in fast-track surgery programmes, non-steroidal anti-inflammatory drugs (NSAIDs) are being prescribed routinely. However, doubts have been raised concerning the safety of NSAIDs in terms of anastomotic healing.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>Data on patients who had undergone primary colorectal anastomosis at two teaching hospitals between January 2008 and December 2010 were analysed retrospectively. Exact use of NSAIDs was recorded. Rates of anastomotic leakage were compared between groups and corrected for known risk factors in both univariable and multivariable analyses.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>A total of 795 patients were divided into four groups according to NSAID use: no NSAIDs (471 patients), use of non-selective NSAIDs (201), use of selective cyclo-oxygenase (COX) 2 inhibitors (79), and use of both selective and non-selective NSAIDs (44). The overall leak rate was 9·9 per cent (10·0 per cent for right colonic, 8·7 per cent for left colonic and 12·4 per cent for rectal anastomoses). Known risk factors such as smoking and use of steroids were not significantly associated with anastomotic leakage. Stapled anastomosis was identified as an independent predictor of leakage in multivariable analysis (odds ratio (OR) 2·22, 95 per cent confidence interval 1·30 to 3·80; <em>P</em> = 0·003). Patients on NSAIDs had higher anastomotic leakage rates than those not on NSAIDs (13·2 <em>versus</em> 7·6 per cent; OR 1·84, 1·13 to 2·98; <em>P</em> = 0·010). This effect was mainly due to non-selective NSAIDs (14·5 per cent; OR 2·13, 1·24 to 3·65; <em>P</em> = 0·006), not selective COX-2 inhibitors (9 per cent; OR 1·16, 0·49 to 2·75; <em>P</em> = 0·741). The overall mortality rate was 4·2 per cent, with no significant difference between groups (<em>P</em> = 0·438).</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>Non-selective NSAIDs may be associated with anastomotic leakage. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:With the implementation of multimodal analgesia regimens in fast-track surgery programmes, non-steroidal anti-inflammatory drugs (NSAIDs) are being prescribed routinely. However, doubts have been raised concerning the safety of NSAIDs in terms of anastomotic healing.Methods:Data on patients who had undergone primary colorectal anastomosis at two teaching hospitals between January 2008 and December 2010 were analysed retrospectively. Exact use of NSAIDs was recorded. Rates of anastomotic leakage were compared between groups and corrected for known risk factors in both univariable and multivariable analyses.Results:A total of 795 patients were divided into four groups according to NSAID use: no NSAIDs (471 patients), use of non-selective NSAIDs (201), use of selective cyclo-oxygenase (COX) 2 inhibitors (79), and use of both selective and non-selective NSAIDs (44). The overall leak rate was 9·9 per cent (10·0 per cent for right colonic, 8·7 per cent for left colonic and 12·4 per cent for rectal anastomoses). Known risk factors such as smoking and use of steroids were not significantly associated with anastomotic leakage. Stapled anastomosis was identified as an independent predictor of leakage in multivariable analysis (odds ratio (OR) 2·22, 95 per cent confidence interval 1·30 to 3·80; P = 0·003). Patients on NSAIDs had higher anastomotic leakage rates than those not on NSAIDs (13·2 versus 7·6 per cent; OR 1·84, 1·13 to 2·98; P = 0·010). This effect was mainly due to non-selective NSAIDs (14·5 per cent; OR 2·13, 1·24 to 3·65; P = 0·006), not selective COX-2 inhibitors (9 per cent; OR 1·16, 0·49 to 2·75; P = 0·741). The overall mortality rate was 4·2 per cent, with no significant difference between groups (P = 0·438).Conclusion:Non-selective NSAIDs may be associated with anastomotic leakage. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.8686" xmlns="http://purl.org/rss/1.0/"><title>Sex-specific time trends in first admission to hospital for peripheral artery disease in Scotland 1991–2007</title><link>http://dx.doi.org/10.1002%2Fbjs.8686</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Sex-specific time trends in first admission to hospital for peripheral artery disease in Scotland 1991–2007</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. C. Inglis</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. D. Lewsey</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">D. Chandler</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">D. S. Byrne</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">G. D. O. Lowe</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">K. MacIntyre</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-09T05:05:22.249132-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.8686</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.8686</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.8686</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>This study examined trends for all first hospital admissions for peripheral artery disease (PAD) in Scotland from 1991 to 2007 using the Scottish Morbidity Record.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>First admissions to hospital for PAD were defined as an admission to hospital (inpatient and day-case) with a principal diagnosis of PAD, with no previous admission to hospital (principal or secondary diagnosis) for PAD in the previous 10 years.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>From 1991 to 2007, 41 593 individuals were admitted to hospital in Scotland for the first time for PAD. Some 23 016 (55·3 per cent) were men (mean(s.d.) age 65·7(11·7) years) and 18 577 were women (aged 70·4(12·8) years). For both sexes the population rate of first admissions to hospital for PAD declined over the study interval: from 66·7 per 100 000 in 1991-1993 to 39·7 per 100 000 in 2006-2007 among men, and from 43·5 to 29·1 per 100 000 respectively among women. After adjustment, the decline was estimated to be 42 per cent in men and 27 per cent in women (rate ratio for 2007 <em>versus</em> 1991: 0·58 (95 per cent confidence interval 0·55 to 0·62) in men and 0·73 (0·68 to 0·78) in women). The intervention rate fell from 80·8 to 74·4 per cent in men and from 77·9 to 64·9 per cent in women. The proportion of hospital admissions as an emergency or transfer increased, from 23·9 to 40·7 per cent among men and from 30·0 to 49·5 per cent among women.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>First hospital admission for PAD in Scotland declined steadily and substantially between 1991 and 2007, with an increase in the proportion that was unplanned. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:This study examined trends for all first hospital admissions for peripheral artery disease (PAD) in Scotland from 1991 to 2007 using the Scottish Morbidity Record.Methods:First admissions to hospital for PAD were defined as an admission to hospital (inpatient and day-case) with a principal diagnosis of PAD, with no previous admission to hospital (principal or secondary diagnosis) for PAD in the previous 10 years.Results:From 1991 to 2007, 41 593 individuals were admitted to hospital in Scotland for the first time for PAD. Some 23 016 (55·3 per cent) were men (mean(s.d.) age 65·7(11·7) years) and 18 577 were women (aged 70·4(12·8) years). For both sexes the population rate of first admissions to hospital for PAD declined over the study interval: from 66·7 per 100 000 in 1991-1993 to 39·7 per 100 000 in 2006-2007 among men, and from 43·5 to 29·1 per 100 000 respectively among women. After adjustment, the decline was estimated to be 42 per cent in men and 27 per cent in women (rate ratio for 2007 versus 1991: 0·58 (95 per cent confidence interval 0·55 to 0·62) in men and 0·73 (0·68 to 0·78) in women). The intervention rate fell from 80·8 to 74·4 per cent in men and from 77·9 to 64·9 per cent in women. The proportion of hospital admissions as an emergency or transfer increased, from 23·9 to 40·7 per cent among men and from 30·0 to 49·5 per cent among women.Conclusion:First hospital admission for PAD in Scotland declined steadily and substantially between 1991 and 2007, with an increase in the proportion that was unplanned. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.8695" xmlns="http://purl.org/rss/1.0/"><title>Counting the cost of cancer surgery for advanced and metastatic disease</title><link>http://dx.doi.org/10.1002%2Fbjs.8695</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Counting the cost of cancer surgery for advanced and metastatic disease</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">R. C. G. Russell</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">T. Treasure</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-09T05:04:55.309803-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.8695</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.8695</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.8695</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Leading article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Putting cancer surgery into context is vital</p></div>]]></content:encoded><description>Putting cancer surgery into context is vital</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.8692" xmlns="http://purl.org/rss/1.0/"><title>Factors influencing the quality of total mesorectal excision</title><link>http://dx.doi.org/10.1002%2Fbjs.8692</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Factors influencing the quality of total mesorectal excision</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">B. Garlipp</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">H. Ptok</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">U. Schmidt</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">P. Stübs</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">H. Scheidbach</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">F. Meyer</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">I. Gastinger</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">H. Lippert</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-06T07:17:32.141869-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.8692</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.8692</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.8692</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>Total mesorectal excision (TME) has become the standard of care for rectal cancer. Incomplete TME may lead to local recurrence.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>Data from the multicentre observational German Quality Assurance in Rectal Cancer Trial were used. Patients undergoing low anterior resection for rectal cancer between 1 January 2005 and 31 December 2009 were included. Multivariable analysis using a stepwise logistic regression model was performed to identify predictors of suboptimal TME.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>From a total of 6179 patients, complete data sets for 4606 patients were available for analysis. Pathological tumour category higher than T2 (pT3 <em>versus</em> pT1/2: odds ratio (OR) 1·22, 95 per cent confidence interval 1·01 to 1·47), tumour distance from the anal verge less than 8 cm (OR 1·27, 1·05 to 1·53), advanced age (65–80 years: OR 1·25, 1·03 to 1·52; over 80 years: OR 1·60, 1·15 to 2·22), presence of intraoperative complications (OR 1·63, 1·15 to 2·30), monopolar dissection technique (OR 1·43, 1·14 to 1·79) and low case volume (fewer than 20 procedures per year) of the operating surgeon (OR 1·20, 1·06 to 1·36) were independently associated with moderate or poor TME quality.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>TME quality was influenced by patient- and treatment-related factors. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:Total mesorectal excision (TME) has become the standard of care for rectal cancer. Incomplete TME may lead to local recurrence.Methods:Data from the multicentre observational German Quality Assurance in Rectal Cancer Trial were used. Patients undergoing low anterior resection for rectal cancer between 1 January 2005 and 31 December 2009 were included. Multivariable analysis using a stepwise logistic regression model was performed to identify predictors of suboptimal TME.Results:From a total of 6179 patients, complete data sets for 4606 patients were available for analysis. Pathological tumour category higher than T2 (pT3 versus pT1/2: odds ratio (OR) 1·22, 95 per cent confidence interval 1·01 to 1·47), tumour distance from the anal verge less than 8 cm (OR 1·27, 1·05 to 1·53), advanced age (65–80 years: OR 1·25, 1·03 to 1·52; over 80 years: OR 1·60, 1·15 to 2·22), presence of intraoperative complications (OR 1·63, 1·15 to 2·30), monopolar dissection technique (OR 1·43, 1·14 to 1·79) and low case volume (fewer than 20 procedures per year) of the operating surgeon (OR 1·20, 1·06 to 1·36) were independently associated with moderate or poor TME quality.Conclusion:TME quality was influenced by patient- and treatment-related factors. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.8697" xmlns="http://purl.org/rss/1.0/"><title>Intraoperative, postoperative and reoperative problems with ileoanal pouches</title><link>http://dx.doi.org/10.1002%2Fbjs.8697</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Intraoperative, postoperative and reoperative problems with ileoanal pouches</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">P. M. Sagar</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. H. Pemberton</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-03T05:25:49.804652-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.8697</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.8697</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.8697</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Review</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>Proctocolectomy with ileal pouch-anal anastomosis (IPAA) has been developed and refined since its introduction in the late 1970s. Nonetheless, it is a procedure associated with significant morbidity. The aim of this review was to provide a structured approach to the challenges that surgeons and physicians encounter in the management of intraoperative, postoperative and reoperative problems associated with ileoanal pouches.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>The review was based on relevant studies identified from an electronic search of MEDLINE, Embase and PubMed databases from 1975 to April 2011. There were no language or publication year restrictions. Original references in published articles were reviewed.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>Although the majority of patients experience long-term success with an ileoanal pouch, significant morbidity surrounds IPAA. Surgical intervention is often critical to achieve optimal control of the situation.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>A structured management plan will minimize the adverse consequences of the problems associated with pouches. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:Proctocolectomy with ileal pouch-anal anastomosis (IPAA) has been developed and refined since its introduction in the late 1970s. Nonetheless, it is a procedure associated with significant morbidity. The aim of this review was to provide a structured approach to the challenges that surgeons and physicians encounter in the management of intraoperative, postoperative and reoperative problems associated with ileoanal pouches.Methods:The review was based on relevant studies identified from an electronic search of MEDLINE, Embase and PubMed databases from 1975 to April 2011. There were no language or publication year restrictions. Original references in published articles were reviewed.Results:Although the majority of patients experience long-term success with an ileoanal pouch, significant morbidity surrounds IPAA. Surgical intervention is often critical to achieve optimal control of the situation.Conclusion:A structured management plan will minimize the adverse consequences of the problems associated with pouches. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.8693" xmlns="http://purl.org/rss/1.0/"><title>Effect of Roux-en-Y gastric bypass on testosterone and prostate-specific antigen</title><link>http://dx.doi.org/10.1002%2Fbjs.8693</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Effect of Roux-en-Y gastric bypass on testosterone and prostate-specific antigen</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">G. Woodard</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. Ahmed</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">V. Podelski</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">T. Hernandez-Boussard</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. Presti</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. M. Morton</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-02-02T08:12:26.549078-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.8693</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.8693</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.8693</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>Obese men have lower serum levels of testosterone, dehydroepiandrosterone (DHEA) and prostate-specific antigen (PSA), but an increased risk of dying from prostate cancer. The aim of this study was to examine the effect of surgically induced weight loss on serum testosterone, DHEA and PSA levels in obese men.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>Consecutive men undergoing Roux-en-<span class="math"><img alt="equation image" src="http://onlinelibrary.wiley.com/store/10.1002/bjs.8693/asset/equation/tex2gif-ueqn-1.gif?v=1&amp;t=gykonw80&amp;s=c74862a867c8fec8499a26bc7b3792ba3c255286" class="inlineGraphic"/></span> gastric bypass (RYGB) participated in a prospective, longitudinal study. Main outcomes were changes were body mass index (BMI), percentage excess weight loss, serum levels of testosterone, DHEA and PSA, PSA mass and plasma volume, measured before operation and 3, 6 and 12 months later.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>In 64 patients, mean BMI fell from 48·2 kg/m<sup>2</sup> before operation to 39·2, 35·6 and 32·4 kg/m<sup>2</sup> at 3, 6 and 12 months after RYGB. Testosterone levels rose significantly from 259 ng/dl to 386, 452 and 520 ng/dl respectively. Serum PSA levels increased significantly from 0·51 ng/ml to 0·67 ng/ml at 12 months. There were no significant changes in DHEA or PSA mass.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>RYGB normalizes the serum testosterone level. PSA levels increase with weight loss and may be inversely correlated with changes in plasma volume, indicating that PSA levels may be artificially low in obese men owing to haemodilution. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:Obese men have lower serum levels of testosterone, dehydroepiandrosterone (DHEA) and prostate-specific antigen (PSA), but an increased risk of dying from prostate cancer. The aim of this study was to examine the effect of surgically induced weight loss on serum testosterone, DHEA and PSA levels in obese men.Methods:Consecutive men undergoing Roux-en-$\font\ss=cmss10 scaled 1000 \hbox{Y}$ gastric bypass (RYGB) participated in a prospective, longitudinal study. Main outcomes were changes were body mass index (BMI), percentage excess weight loss, serum levels of testosterone, DHEA and PSA, PSA mass and plasma volume, measured before operation and 3, 6 and 12 months later.Results:In 64 patients, mean BMI fell from 48·2 kg/m2 before operation to 39·2, 35·6 and 32·4 kg/m2 at 3, 6 and 12 months after RYGB. Testosterone levels rose significantly from 259 ng/dl to 386, 452 and 520 ng/dl respectively. Serum PSA levels increased significantly from 0·51 ng/ml to 0·67 ng/ml at 12 months. There were no significant changes in DHEA or PSA mass.Conclusion:RYGB normalizes the serum testosterone level. PSA levels increase with weight loss and may be inversely correlated with changes in plasma volume, indicating that PSA levels may be artificially low in obese men owing to haemodilution. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.8688" xmlns="http://purl.org/rss/1.0/"><title>Randomized clinical trial of antibiotics in acute uncomplicated diverticulitis</title><link>http://dx.doi.org/10.1002%2Fbjs.8688</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Randomized clinical trial of antibiotics in acute uncomplicated diverticulitis</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. Chabok</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">L. Påhlman</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">F. Hjern</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. Haapaniemi</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">K. Smedh</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-30T07:25:43.041707-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.8688</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.8688</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.8688</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Randomized Clinical Trial</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>The standard of care for acute uncomplicated diverticulitis today is antibiotic treatment, although there are no controlled studies supporting this management. The aim was to investigate the need for antibiotic treatment in acute uncomplicated diverticulitis, with the endpoint of recovery without complications after 12 months of follow-up.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>This multicentre randomized trial involving ten surgical departments in Sweden and one in Iceland recruited 623 patients with computed tomography-verified acute uncomplicated left-sided diverticulitis. Patients were randomized to treatment with (314 patients) or without (309 patients) antibiotics.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>Age, sex, body mass index, co-morbidities, body temperature, white blood cell count and C-reactive protein level on admission were similar in the two groups. Complications such as perforation or abscess formation were found in six patients (1·9 per cent) who received no antibiotics and in three (1·0 per cent) who were treated with antibiotics (<em>P</em> = 0·302). The median hospital stay was 3 days in both groups. Recurrent diverticulitis necessitating readmission to hospital at the 1-year follow-up was similar in the two groups (16 per cent, <em>P</em> = 0·881).</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>Antibiotic treatment for acute uncomplicated diverticulitis neither accelerates recovery nor prevents complications or recurrence. It should be reserved for the treatment of complicated diverticulitis. Registration number: NCT01008488 (<!--TODO: clickthrough URL--><a href="http://www.clinicaltrials.gov" title="Link to external resource: http://www.clinicaltrials.gov">http://www.clinicaltrials.gov</a>). Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:The standard of care for acute uncomplicated diverticulitis today is antibiotic treatment, although there are no controlled studies supporting this management. The aim was to investigate the need for antibiotic treatment in acute uncomplicated diverticulitis, with the endpoint of recovery without complications after 12 months of follow-up.Methods:This multicentre randomized trial involving ten surgical departments in Sweden and one in Iceland recruited 623 patients with computed tomography-verified acute uncomplicated left-sided diverticulitis. Patients were randomized to treatment with (314 patients) or without (309 patients) antibiotics.Results:Age, sex, body mass index, co-morbidities, body temperature, white blood cell count and C-reactive protein level on admission were similar in the two groups. Complications such as perforation or abscess formation were found in six patients (1·9 per cent) who received no antibiotics and in three (1·0 per cent) who were treated with antibiotics (P = 0·302). The median hospital stay was 3 days in both groups. Recurrent diverticulitis necessitating readmission to hospital at the 1-year follow-up was similar in the two groups (16 per cent, P = 0·881).Conclusion:Antibiotic treatment for acute uncomplicated diverticulitis neither accelerates recovery nor prevents complications or recurrence. It should be reserved for the treatment of complicated diverticulitis. Registration number: NCT01008488 (http://www.clinicaltrials.gov). Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.8684" xmlns="http://purl.org/rss/1.0/"><title>Reoperative surgery for bilateral multinodular goitre in the era of total thyroidectomy</title><link>http://dx.doi.org/10.1002%2Fbjs.8684</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Reoperative surgery for bilateral multinodular goitre in the era of total thyroidectomy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">G. Vasica</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">C. J. O'Neill</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. B. Sidhu</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. S. Sywak</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">T. S. Reeve</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">L. W. Delbridge</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-30T04:28:42.416315-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.8684</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.8684</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.8684</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>Total thyroidectomy, rather than bilateral subtotal thyroidectomy, is now accepted as the preferred management for bilateral benign multinodular goitre (BMNG) in order to reduce the need for reoperative surgery. The aim of this study was to examine whether this approach has had an impact on presentation for bilateral reoperative thyroid surgery.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>This was a retrospective cohort study. The study group comprised patients presenting with recurrent BMNG who underwent bilateral reoperative thyroid surgery following previous bilateral subtotal or partial thyroidectomy. They were compared with patients undergoing unilateral reoperative thyroid surgery following previous lobectomy, and those undergoing primary total thyroidectomy for BMNG.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>Between 1 January 1987 and 31 December 2009, 12 354 consecutive thyroid procedures were undertaken. Among those with BMNG, primary total thyroidectomy was undertaken in 3298 patients, unilateral reoperative thyroidectomy in 337 and bilateral reoperative thyroidectomy in 191. Presentations of patients with recurrent BMNG declined gradually over the study period following the change in policy from subtotal to total thyroidectomy; only five patients (representing less than 0·5 per cent of all thyroid surgery) underwent bilateral reoperative surgery for BMNG in the last year of the study. Four of these patients had their initial operation before 1987 and in another unit, whereas the remaining patient initially had surgery overseas.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>The introduction of a policy of initial total thyroidectomy for bilateral BMNG has essentially eliminated the need for bilateral reoperative surgery for recurrent goitre. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:Total thyroidectomy, rather than bilateral subtotal thyroidectomy, is now accepted as the preferred management for bilateral benign multinodular goitre (BMNG) in order to reduce the need for reoperative surgery. The aim of this study was to examine whether this approach has had an impact on presentation for bilateral reoperative thyroid surgery.Methods:This was a retrospective cohort study. The study group comprised patients presenting with recurrent BMNG who underwent bilateral reoperative thyroid surgery following previous bilateral subtotal or partial thyroidectomy. They were compared with patients undergoing unilateral reoperative thyroid surgery following previous lobectomy, and those undergoing primary total thyroidectomy for BMNG.Results:Between 1 January 1987 and 31 December 2009, 12 354 consecutive thyroid procedures were undertaken. Among those with BMNG, primary total thyroidectomy was undertaken in 3298 patients, unilateral reoperative thyroidectomy in 337 and bilateral reoperative thyroidectomy in 191. Presentations of patients with recurrent BMNG declined gradually over the study period following the change in policy from subtotal to total thyroidectomy; only five patients (representing less than 0·5 per cent of all thyroid surgery) underwent bilateral reoperative surgery for BMNG in the last year of the study. Four of these patients had their initial operation before 1987 and in another unit, whereas the remaining patient initially had surgery overseas.Conclusion:The introduction of a policy of initial total thyroidectomy for bilateral BMNG has essentially eliminated the need for bilateral reoperative surgery for recurrent goitre. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.7819" xmlns="http://purl.org/rss/1.0/"><title>Tissue engineering and the road to whole organs</title><link>http://dx.doi.org/10.1002%2Fbjs.7819</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Tissue engineering and the road to whole organs</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. P. Vacanti</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-30T04:26:22.472883-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.7819</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.7819</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.7819</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Leading article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>A glimpse into the future of surgery</p></div>]]></content:encoded><description>A glimpse into the future of surgery</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.8679" xmlns="http://purl.org/rss/1.0/"><title>Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer</title><link>http://dx.doi.org/10.1002%2Fbjs.8679</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. Segelman</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">F. Granath</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">T. Holm</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. Machado</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">H. Mahteme</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. Martling</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-27T09:47:07.00282-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.8679</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.8679</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.8679</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>This was a population-based cohort study to determine the incidence, prevalence and risk factors for peritoneal carcinomatosis (PC) from colorectal cancer.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>Prospectively collected data were obtained from the Regional Quality Registry. The Cox proportional hazards regression model was used for multivariable analysis of clinicopathological factors to determine independent predictors of PC.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>All 11 124 patients with colorectal cancer in Stockholm County during 1995–2007 were included and followed until 2010. In total, 924 patients (8·3 per cent) had synchronous or metachronous PC. PC was the first and only localization of metastases in 535 patients (4·8 per cent). The prevalence of synchronous PC was 4·3 per cent (477 of 11 124). The cumulative incidence of metachronous PC was 4·2 per cent (447 of 10 646). Independent predictors for metachronous PC were colonic cancer (hazard ratio (HR) 1·77, 95 per cent confidence interval 1·31 to 2·39; <em>P</em> = 0·002 for right-sided colonic cancer), advanced tumour (T) status (HR 9·98, 3·10 to 32·11; <em>P</em> &lt; 0·001 for T4), advanced node (N) status (HR 7·41, 4·78 to 11·51; <em>P</em> &lt; 0·001 for N2 with fewer than 12 lymph nodes examined), emergency surgery (HR 2·11, 1·66 to 2·69; <em>P</em> &lt; 0·001) and non-radical resection of the primary tumour (HR 2·75, 2·10 to 3·61; <em>P</em> &lt; 0·001 for R2 resection). Patients aged &gt; 70 years had a decreased risk of metachronous PC (HR 0·69, 0·55 to 0·87; <em>P</em> = 0·003).</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>PC is common in patients with colorectal cancer and is associated with identifiable risk factors. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:This was a population-based cohort study to determine the incidence, prevalence and risk factors for peritoneal carcinomatosis (PC) from colorectal cancer.Methods:Prospectively collected data were obtained from the Regional Quality Registry. The Cox proportional hazards regression model was used for multivariable analysis of clinicopathological factors to determine independent predictors of PC.Results:All 11 124 patients with colorectal cancer in Stockholm County during 1995–2007 were included and followed until 2010. In total, 924 patients (8·3 per cent) had synchronous or metachronous PC. PC was the first and only localization of metastases in 535 patients (4·8 per cent). The prevalence of synchronous PC was 4·3 per cent (477 of 11 124). The cumulative incidence of metachronous PC was 4·2 per cent (447 of 10 646). Independent predictors for metachronous PC were colonic cancer (hazard ratio (HR) 1·77, 95 per cent confidence interval 1·31 to 2·39; P = 0·002 for right-sided colonic cancer), advanced tumour (T) status (HR 9·98, 3·10 to 32·11; P &lt; 0·001 for T4), advanced node (N) status (HR 7·41, 4·78 to 11·51; P &lt; 0·001 for N2 with fewer than 12 lymph nodes examined), emergency surgery (HR 2·11, 1·66 to 2·69; P &lt; 0·001) and non-radical resection of the primary tumour (HR 2·75, 2·10 to 3·61; P &lt; 0·001 for R2 resection). Patients aged &gt; 70 years had a decreased risk of metachronous PC (HR 0·69, 0·55 to 0·87; P = 0·003).Conclusion:PC is common in patients with colorectal cancer and is associated with identifiable risk factors. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.8660" xmlns="http://purl.org/rss/1.0/"><title>Randomized clinical trial of bilateral subtotal thyroidectomy versus total thyroidectomy for Graves' disease with a 5-year follow-up</title><link>http://dx.doi.org/10.1002%2Fbjs.8660</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Randomized clinical trial of bilateral subtotal thyroidectomy versus total thyroidectomy for Graves' disease with a 5-year follow-up</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. Barczyński</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. Konturek</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. Hubalewska-Dydejczyk</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">F. Gołkowski</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">W. Nowak</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-27T09:46:57.291965-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.8660</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.8660</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.8660</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Randomized Clinical Trial</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>The extent of thyroid resection in Graves' disease remains controversial. The aim of this study was to evaluate long-term results of bilateral subtotal thyroidectomy (BST) compared with total thyroidectomy (TT) in patients with Graves' disease and mild active ophthalmopathy.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>Participants were assigned randomly to BST or TT, and followed for 5 years after surgery. The primary endpoints of the study were the prevalence of recurrent hyperthyroidism and changes in Graves' ophthalmopathy. Secondary endpoints were postoperative transient and permanent paresis of the recurrent laryngeal nerve, and postoperative hypocalcaemia and hypoparathyroidism.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>Two hundred patients were included, of whom 191 (BST 95, TT 96) completed the 5-year follow-up. Recurrent hyperthyroidism occurred in nine patients after BST and in none after TT (<em>P</em> = 0·002). Progression of Graves' ophthalmopathy was observed in nine patients after BST compared with seven following TT (<em>P</em> = 0·586). Transient hypoparathyroidism occurred in 13 and 24 patients respectively (<em>P</em> = 0·047). Permanent hypoparathyroidism was diagnosed in no patient after BST and in one after TT (<em>P</em> = 0·318). No differences were noted in transient or permanent recurrent laryngeal nerve injury.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>TT for Graves' disease prevented recurrent hyperthyroidism but did not prevent the progression of ophthalmopathy compared with BST. Registration number: NCT01408368 (<!--TODO: clickthrough URL--><a href="http://www.clinicaltrials.gov" title="Link to external resource: http://www.clinicaltrials.gov">http://www.clinicaltrials.gov</a>). Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:The extent of thyroid resection in Graves' disease remains controversial. The aim of this study was to evaluate long-term results of bilateral subtotal thyroidectomy (BST) compared with total thyroidectomy (TT) in patients with Graves' disease and mild active ophthalmopathy.Methods:Participants were assigned randomly to BST or TT, and followed for 5 years after surgery. The primary endpoints of the study were the prevalence of recurrent hyperthyroidism and changes in Graves' ophthalmopathy. Secondary endpoints were postoperative transient and permanent paresis of the recurrent laryngeal nerve, and postoperative hypocalcaemia and hypoparathyroidism.Results:Two hundred patients were included, of whom 191 (BST 95, TT 96) completed the 5-year follow-up. Recurrent hyperthyroidism occurred in nine patients after BST and in none after TT (P = 0·002). Progression of Graves' ophthalmopathy was observed in nine patients after BST compared with seven following TT (P = 0·586). Transient hypoparathyroidism occurred in 13 and 24 patients respectively (P = 0·047). Permanent hypoparathyroidism was diagnosed in no patient after BST and in one after TT (P = 0·318). No differences were noted in transient or permanent recurrent laryngeal nerve injury.Conclusion:TT for Graves' disease prevented recurrent hyperthyroidism but did not prevent the progression of ophthalmopathy compared with BST. Registration number: NCT01408368 (http://www.clinicaltrials.gov). Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.7798" xmlns="http://purl.org/rss/1.0/"><title>Use of models in identification and prediction of physiology in critically ill surgical patients</title><link>http://dx.doi.org/10.1002%2Fbjs.7798</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Use of models in identification and prediction of physiology in critically ill surgical patients</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. J. Cohen</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-27T09:46:29.158233-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.7798</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.7798</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.7798</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Review</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>With higher-throughput data acquisition and processing, increasing computational power, and advancing computer and mathematical techniques, modelling of clinical and biological data is advancing rapidly. Although exciting, the goal of recreating or surpassing <em>in silico</em> the clinical insight of the experienced clinician remains difficult. Advances toward this goal and a brief overview of various modelling and statistical techniques constitute the purpose of this review.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>A review of the literature and experience with models and physiological state representation and prediction after injury was undertaken.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>A brief overview of models and the thinking behind their use for surgeons new to the field is presented, including an introduction to visualization and modelling work in surgical care, discussion of state identification and prediction, discussion of causal inference statistical approaches, and a brief introduction to new vital signs and waveform analysis.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>Modelling in surgical critical care can provide a useful adjunct to traditional reductionist biological and clinical analysis. Ultimately the goal is to model computationally the clinical acumen of the experienced clinician. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:With higher-throughput data acquisition and processing, increasing computational power, and advancing computer and mathematical techniques, modelling of clinical and biological data is advancing rapidly. Although exciting, the goal of recreating or surpassing in silico the clinical insight of the experienced clinician remains difficult. Advances toward this goal and a brief overview of various modelling and statistical techniques constitute the purpose of this review.Methods:A review of the literature and experience with models and physiological state representation and prediction after injury was undertaken.Results:A brief overview of models and the thinking behind their use for surgeons new to the field is presented, including an introduction to visualization and modelling work in surgical care, discussion of state identification and prediction, discussion of causal inference statistical approaches, and a brief introduction to new vital signs and waveform analysis.Conclusion:Modelling in surgical critical care can provide a useful adjunct to traditional reductionist biological and clinical analysis. Ultimately the goal is to model computationally the clinical acumen of the experienced clinician. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.8689" xmlns="http://purl.org/rss/1.0/"><title>Systematic review and meta-analysis of randomized clinical trials of self-expanding metallic stents as a bridge to surgery versus emergency surgery for malignant left-sided large bowel obstruction</title><link>http://dx.doi.org/10.1002%2Fbjs.8689</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Systematic review and meta-analysis of randomized clinical trials of self-expanding metallic stents as a bridge to surgery versus emergency surgery for malignant left-sided large bowel obstruction</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">C. J. Tan</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">B. V. M. Dasari</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">K. Gardiner</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-19T11:28:59.439132-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.8689</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.8689</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.8689</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Systematic review</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>Use of self-expanding metallic stents (SEMS) as a bridge to surgery has been suggested as an alternative management for acute malignant left-sided colonic obstruction, as emergency surgery has a high risk of morbidity and mortality. This meta-analysis evaluated high-quality evidence comparing preoperative SEMS with emergency surgery.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>Relevant randomized clinical trials (RCTs) were identified from the Cochrane Central Register of Controlled Trials, MEDLINE, Embase and PubMed (1990–2011). Primary outcomes were primary anastomosis, stoma and in-hospital mortality rates. Secondary outcomes included anastomotic leak, 30-day reoperation and surgical-site infection rates.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>Four RCTs with 234 patients were included. Technical and clinical success rates for stenting were 70·7 per cent (82 of 116) and 69·0 per cent (80 of 116) respectively. The clinical perforation rate was 6·9 per cent (8 of 116) and the silent perforation rate 14 per cent (11 of 77). SEMS intervention resulted in significantly higher successful primary anastomosis (risk ratio (RR) 1·58, 95 per cent confidence interval 1·22 to 2·04; <em>P</em> &lt; 0·001) and lower overall stoma (RR 0·71, 0·56 to 0·89; <em>P</em> = 0·004) rates. There was no difference in primary anastomosis, permanent stoma, in-hospital mortality, anastomotic leak, 30-day reoperation and surgical-site infection rates. Three trials were stopped prematurely, one because the emergency surgery group had a significantly increased anastomotic leak rate, and two others because of stent-related complications and increased 30-day morbidity following SEMS management.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>Technical and clinical success rates for stenting were lower than expected. SEMS is associated with a high incidence of clinical and silent perforation. However, as a bridge to surgery, SEMS has higher successful primary anastomosis and lower overall stoma rates, with no significant difference in complications or mortality. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:Use of self-expanding metallic stents (SEMS) as a bridge to surgery has been suggested as an alternative management for acute malignant left-sided colonic obstruction, as emergency surgery has a high risk of morbidity and mortality. This meta-analysis evaluated high-quality evidence comparing preoperative SEMS with emergency surgery.Methods:Relevant randomized clinical trials (RCTs) were identified from the Cochrane Central Register of Controlled Trials, MEDLINE, Embase and PubMed (1990–2011). Primary outcomes were primary anastomosis, stoma and in-hospital mortality rates. Secondary outcomes included anastomotic leak, 30-day reoperation and surgical-site infection rates.Results:Four RCTs with 234 patients were included. Technical and clinical success rates for stenting were 70·7 per cent (82 of 116) and 69·0 per cent (80 of 116) respectively. The clinical perforation rate was 6·9 per cent (8 of 116) and the silent perforation rate 14 per cent (11 of 77). SEMS intervention resulted in significantly higher successful primary anastomosis (risk ratio (RR) 1·58, 95 per cent confidence interval 1·22 to 2·04; P &lt; 0·001) and lower overall stoma (RR 0·71, 0·56 to 0·89; P = 0·004) rates. There was no difference in primary anastomosis, permanent stoma, in-hospital mortality, anastomotic leak, 30-day reoperation and surgical-site infection rates. Three trials were stopped prematurely, one because the emergency surgery group had a significantly increased anastomotic leak rate, and two others because of stent-related complications and increased 30-day morbidity following SEMS management.Conclusion:Technical and clinical success rates for stenting were lower than expected. SEMS is associated with a high incidence of clinical and silent perforation. However, as a bridge to surgery, SEMS has higher successful primary anastomosis and lower overall stoma rates, with no significant difference in complications or mortality. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.8667" xmlns="http://purl.org/rss/1.0/"><title>Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases</title><link>http://dx.doi.org/10.1002%2Fbjs.8667</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">R. P. Jones</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">R. Jackson</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">D. F. J. Dunne</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">H. Z. Malik</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. W. Fenwick</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">G. J. Poston</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">P. Ghaneh</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-19T07:00:02.505881-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.8667</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.8667</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.8667</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Systematic review</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>The evidence surrounding optimal follow-up after liver resection for colorectal metastases remains unclear. A significant proportion of recurrences occur in the early postoperative period, and some groups advocate more intensive review at this time.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>A systematic review of literature published between January 2003 and May 2010 was performed. Studies that described potentially curative primary resection of colorectal liver metastases that involved a defined follow-up protocol and long-term survival data were included. For meta-analysis, studies were grouped into intensive (more frequent review in the first 5 years after resection) and uniform (same throughout) follow-up.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>Thirty-five studies were identified that met the inclusion criteria, involving 7330 patients. Only five specifically addressed follow-up. Patients undergoing intensive early follow-up had a median survival of 39·8 (95 per cent confidence interval 34·3 to 45·3) months with a 5-year overall survival rate of 41·9 (34·4 to 49·4) per cent. Patients undergoing routine follow-up had a median survival of 40·2 (33·4 to 47·0) months, with a 5-year overall survival rate of 38·4 (32·6 to 44·3) months.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>Evidence regarding follow-up after liver resection is poor. Meta-analysis failed to identify a survival advantage for intensive early follow-up. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:The evidence surrounding optimal follow-up after liver resection for colorectal metastases remains unclear. A significant proportion of recurrences occur in the early postoperative period, and some groups advocate more intensive review at this time.Methods:A systematic review of literature published between January 2003 and May 2010 was performed. Studies that described potentially curative primary resection of colorectal liver metastases that involved a defined follow-up protocol and long-term survival data were included. For meta-analysis, studies were grouped into intensive (more frequent review in the first 5 years after resection) and uniform (same throughout) follow-up.Results:Thirty-five studies were identified that met the inclusion criteria, involving 7330 patients. Only five specifically addressed follow-up. Patients undergoing intensive early follow-up had a median survival of 39·8 (95 per cent confidence interval 34·3 to 45·3) months with a 5-year overall survival rate of 41·9 (34·4 to 49·4) per cent. Patients undergoing routine follow-up had a median survival of 40·2 (33·4 to 47·0) months, with a 5-year overall survival rate of 38·4 (32·6 to 44·3) months.Conclusion:Evidence regarding follow-up after liver resection is poor. Meta-analysis failed to identify a survival advantage for intensive early follow-up. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.8665" xmlns="http://purl.org/rss/1.0/"><title>Unresectable colorectal cancer liver metastases treated by intraoperative radiofrequency ablation with or without resection</title><link>http://dx.doi.org/10.1002%2Fbjs.8665</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Unresectable colorectal cancer liver metastases treated by intraoperative radiofrequency ablation with or without resection</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. Evrard</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. Rivoire</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J.-P. Arnaud</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">E. Lermite</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">C. Bellera</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. Fonck</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Y. Becouarn</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">C. Lalet</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. Pulido</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. Mathoulin-Pelissier</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-16T07:20:27.049779-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.8665</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.8665</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.8665</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>Despite neoadjuvant chemotherapy, few patients with colorectal cancer liver metastases (CRLM) are eligible for liver resection. The aim of the present study was to investigate the efficacy of intraoperative radiofrequency ablation (IRFA) in the treatment of unresectable CRLM.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>Patients with unresectable metastases confined to the liver were eligible for this prospective, multicentre phase II study conducted between 2003 and 2008. They received IRFA treatment either with or without parenchymal resection, and underwent clinical and pathological examinations. The primary endpoint was complete hepatic response at 3 months. Overall, event-free and local progression-free survival, morbidity and quality of life were also examined.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>Fifty-two patients were included, all of whom received neoadjuvant chemotherapy. They had a median of 5 (range 1–13) metastases, mostly bilateral or recurrent. A complete hepatic response was observed in 39 patients (75 (95 per cent confidence interval (c.i.) 61 to 86) per cent). Of ten patients with hepatic recurrence at 3 months, two relapses were at the site of ablation. Median follow-up was 2·9 (95 per cent c.i. 2·5 to 3·6) years. The 1-year local progression-free survival rate was 46 (95 per cent c.i. 32 to 59) per cent, the 3-year event-free survival rate was 10 (95 per cent c.i. 4 to 21) per cent and the 5-year overall survival rate was 43 (95 per cent c.i. 21 to 64) per cent. Twenty patients had postoperative complications, including one death. Quality of life increased over time for patients without disease progression.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>IRFA, either with or without resection, is a promising treatment option for patients with unresectable CRLM. Registration number: NTC00210106 (<!--TODO: clickthrough URL--><a href="http://www.clinicaltrials.gov" title="Link to external resource: http://www.clinicaltrials.gov">http://www.clinicaltrials.gov</a>). Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:Despite neoadjuvant chemotherapy, few patients with colorectal cancer liver metastases (CRLM) are eligible for liver resection. The aim of the present study was to investigate the efficacy of intraoperative radiofrequency ablation (IRFA) in the treatment of unresectable CRLM.Methods:Patients with unresectable metastases confined to the liver were eligible for this prospective, multicentre phase II study conducted between 2003 and 2008. They received IRFA treatment either with or without parenchymal resection, and underwent clinical and pathological examinations. The primary endpoint was complete hepatic response at 3 months. Overall, event-free and local progression-free survival, morbidity and quality of life were also examined.Results:Fifty-two patients were included, all of whom received neoadjuvant chemotherapy. They had a median of 5 (range 1–13) metastases, mostly bilateral or recurrent. A complete hepatic response was observed in 39 patients (75 (95 per cent confidence interval (c.i.) 61 to 86) per cent). Of ten patients with hepatic recurrence at 3 months, two relapses were at the site of ablation. Median follow-up was 2·9 (95 per cent c.i. 2·5 to 3·6) years. The 1-year local progression-free survival rate was 46 (95 per cent c.i. 32 to 59) per cent, the 3-year event-free survival rate was 10 (95 per cent c.i. 4 to 21) per cent and the 5-year overall survival rate was 43 (95 per cent c.i. 21 to 64) per cent. Twenty patients had postoperative complications, including one death. Quality of life increased over time for patients without disease progression.Conclusion:IRFA, either with or without resection, is a promising treatment option for patients with unresectable CRLM. Registration number: NTC00210106 (http://www.clinicaltrials.gov). Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.8677" xmlns="http://purl.org/rss/1.0/"><title>Systematic review of outcomes after intersphincteric resection for low rectal cancer</title><link>http://dx.doi.org/10.1002%2Fbjs.8677</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Systematic review of outcomes after intersphincteric resection for low rectal cancer</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. T. Martin</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">H. M. Heneghan</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">D. C. Winter</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-13T08:03:58.729028-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.8677</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.8677</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.8677</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Systematic review</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>For a select group of patients proctectomy with intersphincteric resection (ISR) for low rectal cancer may be a viable alternative to abdominoperineal resection, with good oncological outcomes while preserving sphincter function. The purpose of this systematic review was to evaluate the current evidence regarding oncological outcomes, morbidity and mortality, and functional outcomes after ISR for low rectal cancer.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>A systematic review of the literature was undertaken to evaluate evidence regarding oncological outcomes, morbidity and mortality after ISR for low rectal cancer. Three major databases (PubMed, MEDLINE and the Cochrane Library) were searched. The review included all original articles reporting outcomes after ISR, published in English, from January 1950 to March 2011.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>Eighty-four studies were identified. After applying inclusion and exclusion criteria, 14 studies involving 1289 patients were included (mean age 59·5 years, 67·0 per cent men). R0 resection was achieved by ISR in 97·0 per cent. The operative mortality rate was 0·8 per cent and the cumulative morbidity rate 25·8 per cent. Median follow-up was 56 (range 1–227) months. The mean local recurrence rate was 6·7 (range 0–23) per cent. Mean 5-year overall and disease-free survival rates were 86·3 and 78·6 per cent respectively. Functional outcome was reported in eight studies; among these, the mean number of bowel motions in a 24-h period was 2·7.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>Oncological outcomes after ISR for low rectal cancer are acceptable, with diverse, often imperfect functional results. These data will aid the clinician when counselling patients considering an ISR for management of low rectal cancer. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:For a select group of patients proctectomy with intersphincteric resection (ISR) for low rectal cancer may be a viable alternative to abdominoperineal resection, with good oncological outcomes while preserving sphincter function. The purpose of this systematic review was to evaluate the current evidence regarding oncological outcomes, morbidity and mortality, and functional outcomes after ISR for low rectal cancer.Methods:A systematic review of the literature was undertaken to evaluate evidence regarding oncological outcomes, morbidity and mortality after ISR for low rectal cancer. Three major databases (PubMed, MEDLINE and the Cochrane Library) were searched. The review included all original articles reporting outcomes after ISR, published in English, from January 1950 to March 2011.Results:Eighty-four studies were identified. After applying inclusion and exclusion criteria, 14 studies involving 1289 patients were included (mean age 59·5 years, 67·0 per cent men). R0 resection was achieved by ISR in 97·0 per cent. The operative mortality rate was 0·8 per cent and the cumulative morbidity rate 25·8 per cent. Median follow-up was 56 (range 1–227) months. The mean local recurrence rate was 6·7 (range 0–23) per cent. Mean 5-year overall and disease-free survival rates were 86·3 and 78·6 per cent respectively. Functional outcome was reported in eight studies; among these, the mean number of bowel motions in a 24-h period was 2·7.Conclusion:Oncological outcomes after ISR for low rectal cancer are acceptable, with diverse, often imperfect functional results. These data will aid the clinician when counselling patients considering an ISR for management of low rectal cancer. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.7823" xmlns="http://purl.org/rss/1.0/"><title>Body composition and outcome in patients undergoing resection of colorectal liver metastases</title><link>http://dx.doi.org/10.1002%2Fbjs.7823</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Body composition and outcome in patients undergoing resection of colorectal liver metastases</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. G. van Vledder</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. Levolger</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">N. Ayez</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">C. Verhoef</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">T. C. K. Tran</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. N. M. IJzermans</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-13T05:40:33.856205-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.7823</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.7823</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.7823</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>Recent evidence suggests that depletion of skeletal muscle mass (sarcopenia) and an increased amount of intra-abdominal fat (central obesity) influence cancer statistics. This study investigated the impact of sarcopenia and central obesity on survival in patients undergoing liver resection for colorectal liver metastases (CLM).</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>Diagnostic imaging from patients who had hepatic resection for CLM in one centre between 2001 and 2009, and who had assessable perioperative computed tomograms, was analysed retrospectively. Total cross-sectional areas of skeletal muscle and intra-abdominal fat, and their influence on outcome, were analysed.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>Of the 196 patients included in the study, 38 (19·4 per cent) were classified as having sarcopenia. Five-year disease-free (15 per cent <em>versus</em> 28·5 per cent in patients without sarcopenia; <em>P</em> = 0·002) and overall (20 per cent <em>versus</em> 49·9 per cent respectively; <em>P</em> &lt; 0·001) survival rates were lower for patients with sarcopenia at a median follow-up of 29 (range 1–97) months. Sarcopenia was an independent predictor of worse recurrence-free (hazard ratio (HR) 1·88, 95 per cent confidence interval 1·25 to 2·82; <em>P</em> = 0·002) and overall (HR 2·53, 1·60 to 4·01; <em>P</em> &lt; 0·001) survival. Central obesity was associated with an increased risk of recurrence in men (<em>P</em> = 0·032), but not in women (<em>P</em> = 0·712).</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>Sarcopenia has a negative impact on cancer outcomes following resection of CLM. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:Recent evidence suggests that depletion of skeletal muscle mass (sarcopenia) and an increased amount of intra-abdominal fat (central obesity) influence cancer statistics. This study investigated the impact of sarcopenia and central obesity on survival in patients undergoing liver resection for colorectal liver metastases (CLM).Methods:Diagnostic imaging from patients who had hepatic resection for CLM in one centre between 2001 and 2009, and who had assessable perioperative computed tomograms, was analysed retrospectively. Total cross-sectional areas of skeletal muscle and intra-abdominal fat, and their influence on outcome, were analysed.Results:Of the 196 patients included in the study, 38 (19·4 per cent) were classified as having sarcopenia. Five-year disease-free (15 per cent versus 28·5 per cent in patients without sarcopenia; P = 0·002) and overall (20 per cent versus 49·9 per cent respectively; P &lt; 0·001) survival rates were lower for patients with sarcopenia at a median follow-up of 29 (range 1–97) months. Sarcopenia was an independent predictor of worse recurrence-free (hazard ratio (HR) 1·88, 95 per cent confidence interval 1·25 to 2·82; P = 0·002) and overall (HR 2·53, 1·60 to 4·01; P &lt; 0·001) survival. Central obesity was associated with an increased risk of recurrence in men (P = 0·032), but not in women (P = 0·712).Conclusion:Sarcopenia has a negative impact on cancer outcomes following resection of CLM. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.7796" xmlns="http://purl.org/rss/1.0/"><title>Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer</title><link>http://dx.doi.org/10.1002%2Fbjs.7796</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">D. Pettersson</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">T. Holm</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">H. Iversen</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">L. Blomqvist</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">B. Glimelius</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. Martling</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-12T05:02:12.059182-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.7796</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.7796</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.7796</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>Short-course radiotherapy (SRT) with immediate surgery and long-course chemoradiotherapy (CRT) are currently the standard preoperative treatment options for rectal cancer. SRT with surgery delayed for 4–8 weeks (SRT-delay) is an option described for patients with locally advanced tumours who are not fit for CRT. This study examined early toxicity, response to radiotherapy (RT) and short-term outcomes of SRT-delay.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>Patients in the Stockholm region diagnosed with rectal cancer between January 2002 and December 2008, who received SRT (25 Gy over 5–7 days) and had surgery with resection of the primary tumour more than 4 weeks after the start of RT, were identified from a prospective register. Additional data were obtained by retrospective review of clinical records.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>A total of 112 patients had SRT and delayed surgery. The reasons given for SRT included primary unresectable disease and co-morbidities. Severe RT-induced toxicity was noted in six patients (5·4 per cent). Signs of tumour regression were seen on magnetic resonance imaging in 74 per cent of patients reassessed after RT. Pathological stage (44·9 <em>versus</em> 60·7 per cent stage 0–II; <em>P</em> &lt; 0·001), tumour category (11·9 <em>versus</em> 29·4 per cent T0–T2; <em>P</em> &lt; 0·001) and node category (45·8 <em>versus</em> 63·6 per cent N0; <em>P</em> = 0·014) were significantly lower than those at initial assessment. Nine patients (8·0 per cent) had a complete pathological response.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>The SRT-delay schedule was a feasible alternative with low toxicity. The study indicated a downstaging effect of SRT if surgery was delayed. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:Short-course radiotherapy (SRT) with immediate surgery and long-course chemoradiotherapy (CRT) are currently the standard preoperative treatment options for rectal cancer. SRT with surgery delayed for 4–8 weeks (SRT-delay) is an option described for patients with locally advanced tumours who are not fit for CRT. This study examined early toxicity, response to radiotherapy (RT) and short-term outcomes of SRT-delay.Methods:Patients in the Stockholm region diagnosed with rectal cancer between January 2002 and December 2008, who received SRT (25 Gy over 5–7 days) and had surgery with resection of the primary tumour more than 4 weeks after the start of RT, were identified from a prospective register. Additional data were obtained by retrospective review of clinical records.Results:A total of 112 patients had SRT and delayed surgery. The reasons given for SRT included primary unresectable disease and co-morbidities. Severe RT-induced toxicity was noted in six patients (5·4 per cent). Signs of tumour regression were seen on magnetic resonance imaging in 74 per cent of patients reassessed after RT. Pathological stage (44·9 versus 60·7 per cent stage 0–II; P &lt; 0·001), tumour category (11·9 versus 29·4 per cent T0–T2; P &lt; 0·001) and node category (45·8 versus 63·6 per cent N0; P = 0·014) were significantly lower than those at initial assessment. Nine patients (8·0 per cent) had a complete pathological response.Conclusion:The SRT-delay schedule was a feasible alternative with low toxicity. The study indicated a downstaging effect of SRT if surgery was delayed. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.8654" xmlns="http://purl.org/rss/1.0/"><title>Randomized clinical trial of external stent drainage of the pancreatic duct to reduce postoperative pancreatic fistula after pancreaticojejunostomy</title><link>http://dx.doi.org/10.1002%2Fbjs.8654</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Randomized clinical trial of external stent drainage of the pancreatic duct to reduce postoperative pancreatic fistula after pancreaticojejunostomy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">F. Motoi</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. Egawa</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">T. Rikiyama</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Y. Katayose</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. Unno</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-10T06:06:59.183422-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.8654</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.8654</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.8654</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Randomized Clinical Trial</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>Postoperative pancreatic fistula (POPF) remains one of the most common causes of morbidity following pancreaticoduodenectomy (PD). This randomized trial examined whether external stent drainage of the pancreatic duct decreases the rate of POPF after PD and subsequent pancreaticojejunostomy (PJ).</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>Consecutive patients who underwent PD with subsequent construction of a duct-to-mucosa PJ were randomized into a stented and a non-stented group. The primary outcome was the incidence of clinically relevant POPF. Secondary outcomes were morbidity and mortality rates, and hospital stay.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>Of 114 PD procedures, 93 were suitable for inclusion in the study after informed consent. The rate of clinically relevant POPF was significantly lower in the stented group than in the non-stented group: three of 47 (6 per cent) <em>versus</em> ten of 46 (22 per cent) (<em>P</em> = 0·040). Among patients with a dilated duct, rates of POPF were similar in both groups. Among patients with a non-dilated duct, clinically relevant POPF was significantly less common in the stented group than in the non-stented group: two of 21 (10 per cent) <em>versus</em> eight of 20 (40 per cent) (<em>P</em> = 0·033). No significant differences in morbidity or mortality were observed. Univariable analysis identified body mass index (BMI), pancreatic cancer, pancreatic texture, pancreatic duct size and duct stenting as risk factors related to clinically relevant POPF. Multivariable analysis taking these five factors into account identified high BMI (risk ratio (RR) 11·45; <em>P</em> = 0·008), non-dilated duct (RR 5·33; <em>P</em> = 0·046) and no stent (RR 10·38; <em>P</em> = 0·004) as significant risk factors.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>External duct stenting reduced the risk of clinically relevant POPF after PD and subsequent duct-to-mucosa PJ. Registration number: UMIN000000952 (<!--TODO: clickthrough URL--><a href="http://www.umin.ac.jp/ctr/index-j.htm" title="Link to external resource: http://www.umin.ac.jp/ctr/index-j.htm">http://www.umin.ac.jp/ctr/index-j.htm</a>). Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:Postoperative pancreatic fistula (POPF) remains one of the most common causes of morbidity following pancreaticoduodenectomy (PD). This randomized trial examined whether external stent drainage of the pancreatic duct decreases the rate of POPF after PD and subsequent pancreaticojejunostomy (PJ).Methods:Consecutive patients who underwent PD with subsequent construction of a duct-to-mucosa PJ were randomized into a stented and a non-stented group. The primary outcome was the incidence of clinically relevant POPF. Secondary outcomes were morbidity and mortality rates, and hospital stay.Results:Of 114 PD procedures, 93 were suitable for inclusion in the study after informed consent. The rate of clinically relevant POPF was significantly lower in the stented group than in the non-stented group: three of 47 (6 per cent) versus ten of 46 (22 per cent) (P = 0·040). Among patients with a dilated duct, rates of POPF were similar in both groups. Among patients with a non-dilated duct, clinically relevant POPF was significantly less common in the stented group than in the non-stented group: two of 21 (10 per cent) versus eight of 20 (40 per cent) (P = 0·033). No significant differences in morbidity or mortality were observed. Univariable analysis identified body mass index (BMI), pancreatic cancer, pancreatic texture, pancreatic duct size and duct stenting as risk factors related to clinically relevant POPF. Multivariable analysis taking these five factors into account identified high BMI (risk ratio (RR) 11·45; P = 0·008), non-dilated duct (RR 5·33; P = 0·046) and no stent (RR 10·38; P = 0·004) as significant risk factors.Conclusion:External duct stenting reduced the risk of clinically relevant POPF after PD and subsequent duct-to-mucosa PJ. Registration number: UMIN000000952 (http://www.umin.ac.jp/ctr/index-j.htm). Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.8656" xmlns="http://purl.org/rss/1.0/"><title>Scoring system to predict the risk of surgical-site infection after colorectal resection</title><link>http://dx.doi.org/10.1002%2Fbjs.8656</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Scoring system to predict the risk of surgical-site infection after colorectal resection</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">P. Gervaz</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">C. Bandiera-Clerc</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">N. C. Buchs</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M.-C. Eisenring</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">N. Troillet</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">T. Perneger</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. Harbarth</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-09T07:15:23.691972-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.8656</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.8656</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.8656</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>There is no dedicated scoring system for predicting the risk of surgical-site infection (SSI) after resection of the colon or rectum. Generic scores, such as the National Nosocomial Infections Surveillance index, are not used by colorectal surgeons.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>Multivariable analysis of risk factors for SSI was performed in patients who underwent resection of the colon or rectum, and were followed during the first month after operation. A logistic regression model was used to identify determinant variables and construct a predictive score.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>There were 534 patients of whom 114 (21·3 per cent) developed SSI. In multivariable analysis, four parameters correlated with an increased risk of SSI: obesity (odds ratio (OR) 2·93, 95 per cent confidence interval 1·71 to 5·03), contamination class 3–4 (OR 3·33, 2·08 to 5·32), American Society of Anesthesiologists grade III–IV (OR 1·82, 1·14 to 2·90) and open surgery (OR 2·22, 1·01 to 4·88). Each of these contributed 1 point to the risk score. The observed risk of SSI was 5 per cent for a score of 0, 12·0 per cent for a score of 1 point, 18·7 per cent for 2 points, 44 per cent for 3 points and 68 per cent for 4 points. The area under the receiver operating characteristic curve for the score was 0·729.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>A simple clinical score based on four preoperative variables was clinically useful in predicting the risk of SSI in patients undergoing colorectal surgery. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:There is no dedicated scoring system for predicting the risk of surgical-site infection (SSI) after resection of the colon or rectum. Generic scores, such as the National Nosocomial Infections Surveillance index, are not used by colorectal surgeons.Methods:Multivariable analysis of risk factors for SSI was performed in patients who underwent resection of the colon or rectum, and were followed during the first month after operation. A logistic regression model was used to identify determinant variables and construct a predictive score.Results:There were 534 patients of whom 114 (21·3 per cent) developed SSI. In multivariable analysis, four parameters correlated with an increased risk of SSI: obesity (odds ratio (OR) 2·93, 95 per cent confidence interval 1·71 to 5·03), contamination class 3–4 (OR 3·33, 2·08 to 5·32), American Society of Anesthesiologists grade III–IV (OR 1·82, 1·14 to 2·90) and open surgery (OR 2·22, 1·01 to 4·88). Each of these contributed 1 point to the risk score. The observed risk of SSI was 5 per cent for a score of 0, 12·0 per cent for a score of 1 point, 18·7 per cent for 2 points, 44 per cent for 3 points and 68 per cent for 4 points. The area under the receiver operating characteristic curve for the score was 0·729.Conclusion:A simple clinical score based on four preoperative variables was clinically useful in predicting the risk of SSI in patients undergoing colorectal surgery. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.7822" xmlns="http://purl.org/rss/1.0/"><title>Perineal reconstruction after abdominoperineal excision using inferior gluteal artery perforator flaps</title><link>http://dx.doi.org/10.1002%2Fbjs.7822</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Perineal reconstruction after abdominoperineal excision using inferior gluteal artery perforator flaps</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. Hainsworth</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. Al Akash</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">P. Roblin</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">P. Mohanna</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">D. Ross</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. L. George</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-01-09T06:37:09.319462-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.7822</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.7822</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.7822</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>Perineal wound complications following abdominoperineal excision (APE) for low rectal tumours remain an important cause of morbidity and prolonged hospital stay, particularly after chemoradiotherapy. The aim was to assess outcomes after using inferior gluteal artery perforator (IGAP) flaps for immediate perineal reconstruction, and to compare these with the authors' previous experience and published literature on myocutaneous flaps.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>A series of patients who underwent immediate IGAP flap reconstruction after APE between April 2008 and December 2010 were examined retrospectively to determine patient demographics, length of operation, complications (perineal wound and general) and length of hospital stay.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>Forty patients with rectal adenocarcinoma (33 primary and 7 recurrent disease) underwent immediate IGAP flap reconstruction following APE. Median follow-up was 9 months. Neoadjuvant chemoradiotherapy was received by 98 per cent of the patients. Thirty-two patients underwent APE plus IGAP flaps (25 open, 7 laparoscopic), with a median operating time of 402 min, and eight patients had multivisceral resection (MVR) plus IGAP flaps (7 total pelvic exenteration (TPE), 1 abdominosacral resection), with a median duration of surgery of 561 min. There was one death (fatal stroke) and four major flap complications (10 per cent) (1 enteroperineal fistula, and 3 deep wound infections). Median length of hospital stay was 13 days after APE plus IGAP flaps and 27 days following MVR plus IGAP flaps. Late complications occurred in two patients who had vaginal reconstruction and developed perineal hernias requiring revisional surgery.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>Although operating times are long, the IGAP flap is robust, with no flap necrosis observed in this series. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:Perineal wound complications following abdominoperineal excision (APE) for low rectal tumours remain an important cause of morbidity and prolonged hospital stay, particularly after chemoradiotherapy. The aim was to assess outcomes after using inferior gluteal artery perforator (IGAP) flaps for immediate perineal reconstruction, and to compare these with the authors' previous experience and published literature on myocutaneous flaps.Methods:A series of patients who underwent immediate IGAP flap reconstruction after APE between April 2008 and December 2010 were examined retrospectively to determine patient demographics, length of operation, complications (perineal wound and general) and length of hospital stay.Results:Forty patients with rectal adenocarcinoma (33 primary and 7 recurrent disease) underwent immediate IGAP flap reconstruction following APE. Median follow-up was 9 months. Neoadjuvant chemoradiotherapy was received by 98 per cent of the patients. Thirty-two patients underwent APE plus IGAP flaps (25 open, 7 laparoscopic), with a median operating time of 402 min, and eight patients had multivisceral resection (MVR) plus IGAP flaps (7 total pelvic exenteration (TPE), 1 abdominosacral resection), with a median duration of surgery of 561 min. There was one death (fatal stroke) and four major flap complications (10 per cent) (1 enteroperineal fistula, and 3 deep wound infections). Median length of hospital stay was 13 days after APE plus IGAP flaps and 27 days following MVR plus IGAP flaps. Late complications occurred in two patients who had vaginal reconstruction and developed perineal hernias requiring revisional surgery.Conclusion:Although operating times are long, the IGAP flap is robust, with no flap necrosis observed in this series. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.7763" xmlns="http://purl.org/rss/1.0/"><title>Imaging vascular trauma</title><link>http://dx.doi.org/10.1002%2Fbjs.7763</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Imaging vascular trauma</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">B. O. Patterson</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">P. J. Holt</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. Cleanthis</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">N. Tai</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">T. Carrell</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">T. M. Loosemore</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-12-22T05:29:18.09197-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.7763</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.7763</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.7763</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Review</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>Over the past 50 years the management of vascular trauma has changed from mandatory surgical exploration to selective non-operative treatment, where possible. Accurate, non-invasive, diagnostic imaging techniques are the key to this strategy. The purpose of this review was to define optimal first-line imaging in patients with suspected vascular injury in different anatomical regions.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>A systematic review was performed of literature relating to radiological diagnosis of vascular trauma over the past decade (2000–2010). Studies were included if the main focus was initial diagnosis of blunt or penetrating vascular injury and more than ten patients were included.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>Of 1511 titles identified, 58 articles were incorporated in the systematic review. Most described the use of computed tomography angiography (CTA). The application of duplex ultrasonography, magnetic resonance imaging/angiography and transoesophageal echocardiography was described, but significant drawbacks were highlighted for each. CTA displayed acceptable sensitivity and specificity for diagnosing vascular trauma in blunt and penetrating vascular injury within the neck and extremity, as well as for blunt aortic injury.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>Based on the evidence available, CTA should be the first-line investigation for all patients with suspected vascular trauma and no indication for immediate operative intervention. Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:Over the past 50 years the management of vascular trauma has changed from mandatory surgical exploration to selective non-operative treatment, where possible. Accurate, non-invasive, diagnostic imaging techniques are the key to this strategy. The purpose of this review was to define optimal first-line imaging in patients with suspected vascular injury in different anatomical regions.Methods:A systematic review was performed of literature relating to radiological diagnosis of vascular trauma over the past decade (2000–2010). Studies were included if the main focus was initial diagnosis of blunt or penetrating vascular injury and more than ten patients were included.Results:Of 1511 titles identified, 58 articles were incorporated in the systematic review. Most described the use of computed tomography angiography (CTA). The application of duplex ultrasonography, magnetic resonance imaging/angiography and transoesophageal echocardiography was described, but significant drawbacks were highlighted for each. CTA displayed acceptable sensitivity and specificity for diagnosing vascular trauma in blunt and penetrating vascular injury within the neck and extremity, as well as for blunt aortic injury.Conclusion:Based on the evidence available, CTA should be the first-line investigation for all patients with suspected vascular trauma and no indication for immediate operative intervention. Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.7744" xmlns="http://purl.org/rss/1.0/"><title>Systematic review and meta-analysis of antibiotic prophylaxis to prevent infections from chest drains in blunt and penetrating thoracic injuries</title><link>http://dx.doi.org/10.1002%2Fbjs.7744</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Systematic review and meta-analysis of antibiotic prophylaxis to prevent infections from chest drains in blunt and penetrating thoracic injuries</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. Bosman</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. B. de Jong</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. Debeij</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">P. J. van den Broek</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">I. B. Schipper</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-12-02T08:58:12.154122-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.7744</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.7744</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.7744</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Meta-Analysis</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>No consensus exists as to whether antibiotic prophylaxis in tube thoracostomy as primary treatment for traumatic chest injuries reduces the incidence of surgical-site and pleural cavity infections.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>A systematic literature search was performed according to PRISMA guidelines to identify randomized clinical trials on antibiotic prophylaxis in tube thoracostomy for traumatic chest injuries. Data were extracted by two reviewers using piloted forms. Mantel–Haenszel pooled odds ratios (ORs) were calculated with 95 per cent confidence intervals (c.i.).</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>Eleven articles were included, encompassing 1241 chest drains in 1234 patients. Most patients (84·7 per cent) were men, and a penetrating injury mechanism was most common (856, 69·4 per cent). A favourable effect of antibiotic prophylaxis on the incidence of pulmonary infection was found, with an OR for the overall infectious complication rate of 0·24 (95 per cent c.i. 0·12 to 0·49). Patients who received antibiotic prophylaxis had an almost three times lower risk of empyema than those who did not receive antibiotic treatment (OR 0·32, 0·17 to 0·61). A subgroup analysis in patients with penetrating chest injuries showed that antibiotic prophylaxis in these patients reduced the risk of infection after tube thoracostomy (OR 0·28, 0·14 to 0·57), whereas in a relatively small blunt trauma subgroup no effect of antibiotic prophylaxis after blunt thoracic injury was found.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>Infectious complications are less likely to develop when antibiotic prophylaxis is administered to patients with thoracic injuries requiring chest drains after penetrating injury. Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:No consensus exists as to whether antibiotic prophylaxis in tube thoracostomy as primary treatment for traumatic chest injuries reduces the incidence of surgical-site and pleural cavity infections.Methods:A systematic literature search was performed according to PRISMA guidelines to identify randomized clinical trials on antibiotic prophylaxis in tube thoracostomy for traumatic chest injuries. Data were extracted by two reviewers using piloted forms. Mantel–Haenszel pooled odds ratios (ORs) were calculated with 95 per cent confidence intervals (c.i.).Results:Eleven articles were included, encompassing 1241 chest drains in 1234 patients. Most patients (84·7 per cent) were men, and a penetrating injury mechanism was most common (856, 69·4 per cent). A favourable effect of antibiotic prophylaxis on the incidence of pulmonary infection was found, with an OR for the overall infectious complication rate of 0·24 (95 per cent c.i. 0·12 to 0·49). Patients who received antibiotic prophylaxis had an almost three times lower risk of empyema than those who did not receive antibiotic treatment (OR 0·32, 0·17 to 0·61). A subgroup analysis in patients with penetrating chest injuries showed that antibiotic prophylaxis in these patients reduced the risk of infection after tube thoracostomy (OR 0·28, 0·14 to 0·57), whereas in a relatively small blunt trauma subgroup no effect of antibiotic prophylaxis after blunt thoracic injury was found.Conclusion:Infectious complications are less likely to develop when antibiotic prophylaxis is administered to patients with thoracic injuries requiring chest drains after penetrating injury. Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.7706" xmlns="http://purl.org/rss/1.0/"><title>Resuscitative emergency thoracotomy in a Swiss trauma centre</title><link>http://dx.doi.org/10.1002%2Fbjs.7706</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Resuscitative emergency thoracotomy in a Swiss trauma centre</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">T. Lustenberger</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">L. Labler</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. F. Stover</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. J. B. Keel</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2011-12-02T08:57:53.795552-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.7706</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.7706</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.7706</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>Resuscitative emergency thoracotomy (ET) is performed as a salvage manoeuvre for selected patients with trauma. However, reports from European trauma centres are scarce.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>A retrospective analysis was undertaken of injured patients who underwent resuscitative ET in the emergency department (ED) or operating room (OR) between January 1996 and September 2008. Survival in the ED and to hospital discharge was analysed using logistic regression.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>During the study interval 121 patients required a resuscitative thoracotomy, of which 49 (40·5 per cent) were performed in the ED and 72 (59·5 per cent) in the OR. Patients in the OR had higher blood pressure on arrival (median 110 <em>versus</em> 60 mmHg; <em>P</em> &lt; 0·001), were less often in severe haemorrhagic shock (63 <em>versus</em> 94 per cent; <em>P</em> &lt; 0·001), had fewer serious head injuries (Abbreviated Injury Score of 3 or above in 33 <em>versus</em> 53 per cent; <em>P</em> = 0·031) and more often had a penetrating stab wound as the dominating mechanism (25 <em>versus</em> 10 per cent; <em>P</em> = 0·042) compared with those in the ED. Ten patients (20 per cent) survived to hospital discharge after ED thoracotomy, compared with 53 (74 per cent) of those treated in the OR. Penetrating injury and Glasgow Coma Scale score above 8 were independent predictors of hospital survival following ED thoracotomy. No patient with a blunt injury and no detectable signs of life on admission survived. Three of 26 patients with blunt trauma and signs of life on admission survived to hospital discharge.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>Resuscitative ET may be life-saving in selected patients. Location of the procedure is dictated by injury severity and vital parameters. Outcome is best when signs of life are present on admission, even for blunt injuries. Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:Resuscitative emergency thoracotomy (ET) is performed as a salvage manoeuvre for selected patients with trauma. However, reports from European trauma centres are scarce.Methods:A retrospective analysis was undertaken of injured patients who underwent resuscitative ET in the emergency department (ED) or operating room (OR) between January 1996 and September 2008. Survival in the ED and to hospital discharge was analysed using logistic regression.Results:During the study interval 121 patients required a resuscitative thoracotomy, of which 49 (40·5 per cent) were performed in the ED and 72 (59·5 per cent) in the OR. Patients in the OR had higher blood pressure on arrival (median 110 versus 60 mmHg; P &lt; 0·001), were less often in severe haemorrhagic shock (63 versus 94 per cent; P &lt; 0·001), had fewer serious head injuries (Abbreviated Injury Score of 3 or above in 33 versus 53 per cent; P = 0·031) and more often had a penetrating stab wound as the dominating mechanism (25 versus 10 per cent; P = 0·042) compared with those in the ED. Ten patients (20 per cent) survived to hospital discharge after ED thoracotomy, compared with 53 (74 per cent) of those treated in the OR. Penetrating injury and Glasgow Coma Scale score above 8 were independent predictors of hospital survival following ED thoracotomy. No patient with a blunt injury and no detectable signs of life on admission survived. Three of 26 patients with blunt trauma and signs of life on admission survived to hospital discharge.Conclusion:Resuscitative ET may be life-saving in selected patients. Location of the procedure is dictated by injury severity and vital parameters. Outcome is best when signs of life are present on admission, even for blunt injuries. Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.7813" xmlns="http://purl.org/rss/1.0/"><title>The never-ending story of dilatation versus surgery for oesophageal achalasia</title><link>http://dx.doi.org/10.1002%2Fbjs.7813</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The never-ending story of dilatation versus surgery for oesophageal achalasia</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">G. Zaninotto</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. G. Patti</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.7813</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.7813</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.7813</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Leading Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">305</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">306</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Still no clear winner</p></div>]]></content:encoded><description>Still no clear winner</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.7818" xmlns="http://purl.org/rss/1.0/"><title>Recruiting patients into randomized clinical trials in surgery</title><link>http://dx.doi.org/10.1002%2Fbjs.7818</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Recruiting patients into randomized clinical trials in surgery</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. M. Blazeby</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.7818</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.7818</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.7818</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Leading article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">307</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">308</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Surgeons can do better</p></div>]]></content:encoded><description>Surgeons can do better</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.7734" xmlns="http://purl.org/rss/1.0/"><title>A model for rural trauma care</title><link>http://dx.doi.org/10.1002%2Fbjs.7734</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">A model for rural trauma care</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">N. McSwain</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. Rotondo</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">P. Meade</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. Duchesne</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.7734</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.7734</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.7734</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Review</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">309</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">314</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>In the United States and many other countries, there has been limited attempt to develop a trauma system that addresses the unique trauma situations that occur in rural areas. Rather the planners have attempted to simply extend the urban based trauma system into rural communities. This extension does not address the needs of the majority of patients who are injured in rural communities.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>A review of the types of patients seen in the rural communities, the volume of these patients and the destination protocols used in the rural communities as taught by the ACS/ATLS and the implications of the CDC Guidelines for Field Triage of Injured Patients Recommendations of the National Expert Panel on Field Triage were reviewed, assessed and compared to the needs in the rural areas for a rural trauma system. In addition, a quality assessment tool was used from a major trauma centre whereby the frequency of patients transported to the centre that were inappropriate for the trauma centre was indicated by the volume that were discharged in 6 h.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>Most of the patients injured in the rural communities can be treated in the critical access and rural hospital (&gt; 90 per cent) and can be provided with good care without the need for emergency medical service (EMS) transportation long distances to the trauma centre, inappropriate use of air EMS vehicles thus circumventing families having to travel long distances to see patients, incurring expense and inconvenience, and avoiding loss of revenue to the local hospitals and the overload of urban trauma centres. Rather triage criteria can be taught as per the EMS systems, training given to rural hospital personnel, hospital administrators instructed as to the benefit of such a system, citizens educated as to the advantage of keeping their loved ones closer to home and trauma system registries used to enhance the correct use of the trauma system.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>Only 5–10 per cent of trauma injuries require the resources of a trauma centre. Proper triage and medical provider education can be used for the benefit of the patient, the EMS system, the rural and urban hospital, and proper quality assurance to assure that the ‘right patient is treated at the right hospital at the right time’, for the benefit of the patient. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:In the United States and many other countries, there has been limited attempt to develop a trauma system that addresses the unique trauma situations that occur in rural areas. Rather the planners have attempted to simply extend the urban based trauma system into rural communities. This extension does not address the needs of the majority of patients who are injured in rural communities.Methods:A review of the types of patients seen in the rural communities, the volume of these patients and the destination protocols used in the rural communities as taught by the ACS/ATLS and the implications of the CDC Guidelines for Field Triage of Injured Patients Recommendations of the National Expert Panel on Field Triage were reviewed, assessed and compared to the needs in the rural areas for a rural trauma system. In addition, a quality assessment tool was used from a major trauma centre whereby the frequency of patients transported to the centre that were inappropriate for the trauma centre was indicated by the volume that were discharged in 6 h.Results:Most of the patients injured in the rural communities can be treated in the critical access and rural hospital (&gt; 90 per cent) and can be provided with good care without the need for emergency medical service (EMS) transportation long distances to the trauma centre, inappropriate use of air EMS vehicles thus circumventing families having to travel long distances to see patients, incurring expense and inconvenience, and avoiding loss of revenue to the local hospitals and the overload of urban trauma centres. Rather triage criteria can be taught as per the EMS systems, training given to rural hospital personnel, hospital administrators instructed as to the benefit of such a system, citizens educated as to the advantage of keeping their loved ones closer to home and trauma system registries used to enhance the correct use of the trauma system.Conclusion:Only 5–10 per cent of trauma injuries require the resources of a trauma centre. Proper triage and medical provider education can be used for the benefit of the patient, the EMS system, the rural and urban hospital, and proper quality assurance to assure that the ‘right patient is treated at the right hospital at the right time’, for the benefit of the patient. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.7836" xmlns="http://purl.org/rss/1.0/"><title>Systematic review of trocar-site hernia</title><link>http://dx.doi.org/10.1002%2Fbjs.7836</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Systematic review of trocar-site hernia</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">H. A. Swank</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">I. M. Mulder</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">C. F. la Chapelle</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. B. Reitsma</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. F. Lange</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">W. A. Bemelman</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.7836</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.7836</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.7836</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Systematic Review</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">315</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">323</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>Broad implementation of laparoscopic surgery has made trocar-related complications clinically important. Trocar-site hernia (TSH) is an uncommon, but potentially serious, complication that occasionally requires emergency surgery. This systematic review was conducted to establish the prevalence and risk factors for TSH.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>The review was conducted according to the PRISMA guidelines. MEDLINE, Embase, Web of Science and the Cochrane Library were searched to 7 June 2010 for studies on TSH.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>Twenty-two articles were included. One study was a randomized clinical trial, five were prospective cohort studies and 16 were retrospective cohort studies. The prevalence of TSH is low, with a median pooled estimate of 0·5 (range 0–5·2) per cent. No meta-analysis on risk factors could be performed. Pyramidal trocars, 12-mm trocars and a long duration of surgery were identified as the most important technical risk factors for TSH. Older age and a higher body mass index were observed to be patient-related risk factors.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>TSH is an uncommon complication of laparoscopic surgery. The most important technical risk factors are the design and size of the trocars. The scientific evidence for recommendations to avoid TSH is sparse. Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:Broad implementation of laparoscopic surgery has made trocar-related complications clinically important. Trocar-site hernia (TSH) is an uncommon, but potentially serious, complication that occasionally requires emergency surgery. This systematic review was conducted to establish the prevalence and risk factors for TSH.Methods:The review was conducted according to the PRISMA guidelines. MEDLINE, Embase, Web of Science and the Cochrane Library were searched to 7 June 2010 for studies on TSH.Results:Twenty-two articles were included. One study was a randomized clinical trial, five were prospective cohort studies and 16 were retrospective cohort studies. The prevalence of TSH is low, with a median pooled estimate of 0·5 (range 0–5·2) per cent. No meta-analysis on risk factors could be performed. Pyramidal trocars, 12-mm trocars and a long duration of surgery were identified as the most important technical risk factors for TSH. Older age and a higher body mass index were observed to be patient-related risk factors.Conclusion:TSH is an uncommon complication of laparoscopic surgery. The most important technical risk factors are the design and size of the trocars. The scientific evidence for recommendations to avoid TSH is sparse. Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.7803" xmlns="http://purl.org/rss/1.0/"><title>Systematic review of the application of quality improvement methodologies from the manufacturing industry to surgical healthcare</title><link>http://dx.doi.org/10.1002%2Fbjs.7803</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Systematic review of the application of quality improvement methodologies from the manufacturing industry to surgical healthcare</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">C. R. Nicolay</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. Purkayastha</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. Greenhalgh</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. Benn</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. Chaturvedi</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">N. Phillips</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. Darzi</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.7803</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.7803</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.7803</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Systematic review</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">324</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">335</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>The demand for the highest-quality patient care coupled with pressure on funding has led to the increasing use of quality improvement (QI) methodologies from the manufacturing industry. The aim of this systematic review was to identify and evaluate the application and effectiveness of these QI methodologies to the field of surgery.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>MEDLINE, the Cochrane Database, Allied and Complementary Medicine Database, British Nursing Index, Cumulative Index to Nursing and Allied Health Literature, Embase, Health Business<sup>™</sup> Elite, the Health Management Information Consortium and PsycINFO<sup>®</sup> were searched according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Empirical studies were included that implemented a described QI methodology to surgical care and analysed a named outcome statistically.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>Some 34 of 1595 articles identified met the inclusion criteria after consensus from two independent investigators. Nine studies described continuous quality improvement (CQI), five Six Sigma, five total quality management (TQM), five plan-do-study-act (PDSA) or plan-do-check-act (PDCA) cycles, five statistical process control (SPC) or statistical quality control (SQC), four Lean and one Lean Six Sigma; 20 of the studies were undertaken in the USA. The most common aims were to reduce complications or improve outcomes (11), to reduce infection (7), and to reduce theatre delays (7). There was one randomized controlled trial.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>QI methodologies from industry can have significant effects on improving surgical care, from reducing infection rates to increasing operating room efficiency. The evidence is generally of suboptimal quality, and rigorous randomized multicentre studies are needed to bring evidence-based management into the same league as evidence-based medicine. Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:The demand for the highest-quality patient care coupled with pressure on funding has led to the increasing use of quality improvement (QI) methodologies from the manufacturing industry. The aim of this systematic review was to identify and evaluate the application and effectiveness of these QI methodologies to the field of surgery.Methods:MEDLINE, the Cochrane Database, Allied and Complementary Medicine Database, British Nursing Index, Cumulative Index to Nursing and Allied Health Literature, Embase, Health Business™ Elite, the Health Management Information Consortium and PsycINFO® were searched according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Empirical studies were included that implemented a described QI methodology to surgical care and analysed a named outcome statistically.Results:Some 34 of 1595 articles identified met the inclusion criteria after consensus from two independent investigators. Nine studies described continuous quality improvement (CQI), five Six Sigma, five total quality management (TQM), five plan-do-study-act (PDSA) or plan-do-check-act (PDCA) cycles, five statistical process control (SPC) or statistical quality control (SQC), four Lean and one Lean Six Sigma; 20 of the studies were undertaken in the USA. The most common aims were to reduce complications or improve outcomes (11), to reduce infection (7), and to reduce theatre delays (7). There was one randomized controlled trial.Conclusion:QI methodologies from industry can have significant effects on improving surgical care, from reducing infection rates to increasing operating room efficiency. The evidence is generally of suboptimal quality, and rigorous randomized multicentre studies are needed to bring evidence-based management into the same league as evidence-based medicine. Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.8657" xmlns="http://purl.org/rss/1.0/"><title>Systematic review and meta-analysis of the effect of North American working hours restrictions on mortality and morbidity in surgical patients</title><link>http://dx.doi.org/10.1002%2Fbjs.8657</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Systematic review and meta-analysis of the effect of North American working hours restrictions on mortality and morbidity in surgical patients</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. H. Jamal</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. A. R. Doi</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. Rousseau</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. Edwards</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">C. Rao</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. J. Barendregt</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">L. Snell</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. Meterissian</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.8657</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.8657</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.8657</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Systematic review</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">336</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">344</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>Short duty hours, imposed by the Accreditation Council of Graduate Medical Education (ACGME) regulations, have been claimed to be associated with loss of continuity of care among surgical patients, leading to a potentially increased risk of adverse surgical outcomes. This systematic review and meta-analysis assessed the strength of associations between duty hour restrictions and morbidity and mortality of various surgical procedures.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>MEDLINE, Embase, BIOSIS Previews<sup>®</sup>, the Education Resources Information Center and the Cochrane Central Register of Controlled Trials (January 2000 to September 2009) were searched, and reports screened to identify comparative studies of mortality and morbidity before and after the introduction of ACGME regulation periods. Random-effects (RE) and quality-effects (QE) meta-analyses were performed to determine the risk of morbidity or death associated with long duty hours compared with shorter duty hours. Results are presented as odds ratio (OR) with 95 per cent confidence interval.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>A total of 19 data sets (10 articles), including 730 648 subjects in the mortality studies and 64 346 in the morbidity studies, were analysed. Long duty hours were associated with a non-significantly increased risk of death compared with shorter duty hours (OR 1·28, 0·94 to 1·73). There was no difference in morbidity between the two groups (OR 1·03, 0·67 to 1·57). Mortality associations were generally stronger for general surgery, more recent studies and higher-quality studies. Heterogeneity was evident among the studies included.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>The reduction in working hours has not affected patient care negatively in terms of demonstrable differences in morbidity and mortality. However, it cannot be distinguished whether this effect is actually due to a non-detrimental effect of the reduction in working hours or whether any such detriment is offset by continually improving patient care and increased surgical supervision. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:Short duty hours, imposed by the Accreditation Council of Graduate Medical Education (ACGME) regulations, have been claimed to be associated with loss of continuity of care among surgical patients, leading to a potentially increased risk of adverse surgical outcomes. This systematic review and meta-analysis assessed the strength of associations between duty hour restrictions and morbidity and mortality of various surgical procedures.Methods:MEDLINE, Embase, BIOSIS Previews®, the Education Resources Information Center and the Cochrane Central Register of Controlled Trials (January 2000 to September 2009) were searched, and reports screened to identify comparative studies of mortality and morbidity before and after the introduction of ACGME regulation periods. Random-effects (RE) and quality-effects (QE) meta-analyses were performed to determine the risk of morbidity or death associated with long duty hours compared with shorter duty hours. Results are presented as odds ratio (OR) with 95 per cent confidence interval.Results:A total of 19 data sets (10 articles), including 730 648 subjects in the mortality studies and 64 346 in the morbidity studies, were analysed. Long duty hours were associated with a non-significantly increased risk of death compared with shorter duty hours (OR 1·28, 0·94 to 1·73). There was no difference in morbidity between the two groups (OR 1·03, 0·67 to 1·57). Mortality associations were generally stronger for general surgery, more recent studies and higher-quality studies. Heterogeneity was evident among the studies included.Conclusion:The reduction in working hours has not affected patient care negatively in terms of demonstrable differences in morbidity and mortality. However, it cannot be distinguished whether this effect is actually due to a non-detrimental effect of the reduction in working hours or whether any such detriment is offset by continually improving patient care and increased surgical supervision. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.8655" xmlns="http://purl.org/rss/1.0/"><title>Systematic review and meta-analysis of the effect of North American working hours restrictions on mortality and morbidity in surgical patients (Br J Surg 2012; 99: 336–344)</title><link>http://dx.doi.org/10.1002%2Fbjs.8655</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Systematic review and meta-analysis of the effect of North American working hours restrictions on mortality and morbidity in surgical patients (Br J Surg 2012; 99: 336–344)</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">T. S. Helling</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.8655</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.8655</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.8655</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Commentary</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">345</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">345</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.7799" xmlns="http://purl.org/rss/1.0/"><title>Randomized clinical trial of omega-3 fatty acid-supplemented enteral nutrition versus standard enteral nutrition in patients undergoing oesophagogastric cancer surgery</title><link>http://dx.doi.org/10.1002%2Fbjs.7799</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Randomized clinical trial of omega-3 fatty acid-supplemented enteral nutrition versus standard enteral nutrition in patients undergoing oesophagogastric cancer surgery</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. Sultan</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. M. Griffin</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">F. Di Franco</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. A. Kirby</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">B. K. Shenton</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">C. J. Seal</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">P. Davis</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Y. K. S. Viswanath</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. R. Preston</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">N. Hayes</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.7799</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.7799</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.7799</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Randomized Clinical Trial</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">346</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">355</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>Oesophagogastric cancer surgery is immunosuppressive. This may be modulated by omega-3 fatty acids (O-3FAs). The aim of this study was to assess the effect of perioperative O-3FAs on clinical outcome and immune function after oesophagogastric cancer surgery.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>Patients undergoing subtotal oesophagectomy and total gastrectomy were recruited and allocated randomly to an O-3FA enteral immunoenhancing diet (IED) or standard enteral nutrition (SEN) for 7 days before and after surgery, or to postoperative supplementation alone (control group). Clinical outcome, fatty acid concentrations, and HLA-DR expression on monocytes and activated T lymphocytes were determined before and after operation.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>Of 221 patients recruited, 26 were excluded. Groups (IED, 66; SEN, 63; control, 66) were matched for age, malnutrition and co-morbidity. There were no differences in morbidity (<em>P</em> = 0·646), mortality (<em>P</em> = 1·000) or hospital stay (<em>P</em> = 0·701) between the groups. O-3FA concentrations were higher in the IED group after supplementation (<em>P</em> &lt; 0·001). The ratio of omega-6 fatty acid to O-3FA was 1·9:1, 4·1:1 and 4·8:1 on the day before surgery in the IED, SEN and control groups (<em>P</em> &lt; 0·001). There were no differences between the groups in HLA-DR expression in either monocytes (<em>P</em> = 0·538) or activated T lymphocytes (<em>P</em> = 0·204).</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>Despite a significant increase in plasma concentrations of O-3FA, immunonutrition with O-3FA did not affect overall HLA-DR expression on leucocytes or clinical outcome following oesophagogastric cancer surgery. Registration number: ISRCTN43730758 (<!--TODO: clickthrough URL--><a href="http://www.controlled‐trials.com" title="Link to external resource: http://www.controlled‐trials.com">http://www.controlled-trials.com</a>). Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:Oesophagogastric cancer surgery is immunosuppressive. This may be modulated by omega-3 fatty acids (O-3FAs). The aim of this study was to assess the effect of perioperative O-3FAs on clinical outcome and immune function after oesophagogastric cancer surgery.Methods:Patients undergoing subtotal oesophagectomy and total gastrectomy were recruited and allocated randomly to an O-3FA enteral immunoenhancing diet (IED) or standard enteral nutrition (SEN) for 7 days before and after surgery, or to postoperative supplementation alone (control group). Clinical outcome, fatty acid concentrations, and HLA-DR expression on monocytes and activated T lymphocytes were determined before and after operation.Results:Of 221 patients recruited, 26 were excluded. Groups (IED, 66; SEN, 63; control, 66) were matched for age, malnutrition and co-morbidity. There were no differences in morbidity (P = 0·646), mortality (P = 1·000) or hospital stay (P = 0·701) between the groups. O-3FA concentrations were higher in the IED group after supplementation (P &lt; 0·001). The ratio of omega-6 fatty acid to O-3FA was 1·9:1, 4·1:1 and 4·8:1 on the day before surgery in the IED, SEN and control groups (P &lt; 0·001). There were no differences between the groups in HLA-DR expression in either monocytes (P = 0·538) or activated T lymphocytes (P = 0·204).Conclusion:Despite a significant increase in plasma concentrations of O-3FA, immunonutrition with O-3FA did not affect overall HLA-DR expression on leucocytes or clinical outcome following oesophagogastric cancer surgery. Registration number: ISRCTN43730758 (http://www.controlled-trials.com). Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.7762" xmlns="http://purl.org/rss/1.0/"><title>Mass casualty incident training in a resource-limited environment </title><link>http://dx.doi.org/10.1002%2Fbjs.7762</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Mass casualty incident training in a resource-limited environment </dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. J. Leow</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. I. Brundage</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. L. Kushner</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">T. B. Kamara</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">E. Hanciles</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. Muana</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. M. Kamara</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">K. S. Daoh</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">T. P. Kingham</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.7762</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.7762</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.7762</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">356</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">361</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>A mass casualty incident (MCI) occurs when a disaster involves a large number of injured people, overwhelming the capacity of local emergency medical services. This article describes the planning and execution of a MCI workshop created for use in Sierra Leone, a low-income country.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>Surgeons OverSeas (SOS), an international non-governmental organization, partnered with the Sierra Leone Office of National Security and Connaught Hospital to develop a 2-day MCI workshop designed to meet needs specific to their resource-limited environment. Pre- and post-course questionnaires were completed. Day 1 consisted of didactic teaching focused on triage principles, resource deployment, communication/operations and tabletop drills. On day 2 a mock MCI with performance assessments by independent observers was staged, followed by post-event debriefing.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>Pre-course questionnaires identified the following deficits: lack of triage training (29 per cent), and transportation (19 per cent) and communication (17 per cent) shortfalls. Only 11 per cent could define MCI. During the drill, on-scene and hospital triage was accurate in 28 (93 per cent) and 23 (77 per cent) of 30 casualties respectively. Systematic deficiencies identified included: transport issues, no accurate system for tracking victims, and undersized triage areas. Participants identified interagency coordination (63 of 136 responses; 46·3 per cent) and triage (32 of 136; 23·5 per cent) as the most valuable lessons learned.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>Pre-existing MCI programmes based on first-world logistics do not account for challenges encountered when caring for casualties in resource-constrained settings. Logistical training, rather than medical skills or knowledge, was identified as the educational priority. Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:A mass casualty incident (MCI) occurs when a disaster involves a large number of injured people, overwhelming the capacity of local emergency medical services. This article describes the planning and execution of a MCI workshop created for use in Sierra Leone, a low-income country.Methods:Surgeons OverSeas (SOS), an international non-governmental organization, partnered with the Sierra Leone Office of National Security and Connaught Hospital to develop a 2-day MCI workshop designed to meet needs specific to their resource-limited environment. Pre- and post-course questionnaires were completed. Day 1 consisted of didactic teaching focused on triage principles, resource deployment, communication/operations and tabletop drills. On day 2 a mock MCI with performance assessments by independent observers was staged, followed by post-event debriefing.Results:Pre-course questionnaires identified the following deficits: lack of triage training (29 per cent), and transportation (19 per cent) and communication (17 per cent) shortfalls. Only 11 per cent could define MCI. During the drill, on-scene and hospital triage was accurate in 28 (93 per cent) and 23 (77 per cent) of 30 casualties respectively. Systematic deficiencies identified included: transport issues, no accurate system for tracking victims, and undersized triage areas. Participants identified interagency coordination (63 of 136 responses; 46·3 per cent) and triage (32 of 136; 23·5 per cent) as the most valuable lessons learned.Conclusion:Pre-existing MCI programmes based on first-world logistics do not account for challenges encountered when caring for casualties in resource-constrained settings. Logistical training, rather than medical skills or knowledge, was identified as the educational priority. Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.7774" xmlns="http://purl.org/rss/1.0/"><title>Mass casualty incident training in a resource-limited environment (Br J Surg 2012; 99: 356–361)</title><link>http://dx.doi.org/10.1002%2Fbjs.7774</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Mass casualty incident training in a resource-limited environment (Br J Surg 2012; 99: 356–361)</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">T. G. Weiser</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.7774</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.7774</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.7774</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Commentary</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">361</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">361</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.7765" xmlns="http://purl.org/rss/1.0/"><title>Associated injuries in casualties with traumatic lower extremity amputations caused by improvised explosive devices</title><link>http://dx.doi.org/10.1002%2Fbjs.7765</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Associated injuries in casualties with traumatic lower extremity amputations caused by improvised explosive devices</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. J. Morrison</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">N. Hunt</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. Midwinter</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. Jansen</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.7765</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.7765</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.7765</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">362</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">366</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>Improvised explosive devices (IEDs) pose a significant threat to military personnel, often resulting in lower extremity amputation and pelvic injury. Immediate management is haemorrhage control and debridement, which can involve lengthy surgery. Computed tomography is necessary to delineate the extent of the injury, but it is unclear whether to perform this during or after surgery.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>The UK Joint Theatre Trauma Registry was searched to identify all UK service personnel who had a traumatic lower extremity amputation following IED injury between January 2007 and December 2010. Data were collected on injury pattern and survival.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>There were 169 patients who sustained 278 traumatic lower extremity amputations: 69 were killed in action, 16 died from their wounds and 84 were wounded in action, but survived. The median (interquartile range) Injury Severity Score was 75 (21) for those killed in action, 46 (23) for those who died from wounds and 29 (12) for survivors. There were significantly more severe head, chest and abdominal injuries (defined as a body region Abbreviated Injury Scale score of 3 or more) in patients who were killed in action than in those reaching hospital (<em>P</em> &lt; 0·001). Hindquarter amputations were the most lethal, with a mortality rate of 95 per cent. Of the 100 casualties who reached hospital alive, there were nine thoracotomies, one craniotomy and 34 laparotomies. All head or torso injuries that required immediate operation were clinically apparent on admission.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>Higher levels of amputation were associated with greater injury burden and mortality. Intraoperative computed tomography had little value in identifying clinically significant covert injuries. © 2011 Crown copyright Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:Improvised explosive devices (IEDs) pose a significant threat to military personnel, often resulting in lower extremity amputation and pelvic injury. Immediate management is haemorrhage control and debridement, which can involve lengthy surgery. Computed tomography is necessary to delineate the extent of the injury, but it is unclear whether to perform this during or after surgery.Methods:The UK Joint Theatre Trauma Registry was searched to identify all UK service personnel who had a traumatic lower extremity amputation following IED injury between January 2007 and December 2010. Data were collected on injury pattern and survival.Results:There were 169 patients who sustained 278 traumatic lower extremity amputations: 69 were killed in action, 16 died from their wounds and 84 were wounded in action, but survived. The median (interquartile range) Injury Severity Score was 75 (21) for those killed in action, 46 (23) for those who died from wounds and 29 (12) for survivors. There were significantly more severe head, chest and abdominal injuries (defined as a body region Abbreviated Injury Scale score of 3 or more) in patients who were killed in action than in those reaching hospital (P &lt; 0·001). Hindquarter amputations were the most lethal, with a mortality rate of 95 per cent. Of the 100 casualties who reached hospital alive, there were nine thoracotomies, one craniotomy and 34 laparotomies. All head or torso injuries that required immediate operation were clinically apparent on admission.Conclusion:Higher levels of amputation were associated with greater injury burden and mortality. Intraoperative computed tomography had little value in identifying clinically significant covert injuries. © 2011 Crown copyright Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.7768" xmlns="http://purl.org/rss/1.0/"><title>Associated injuries in casualties with traumatic lower extremity amputations caused by improvised explosive devices (Br J Surg 2012; 99: 362–366)</title><link>http://dx.doi.org/10.1002%2Fbjs.7768</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Associated injuries in casualties with traumatic lower extremity amputations caused by improvised explosive devices (Br J Surg 2012; 99: 362–366)</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. B. Holcomb</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.7768</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.7768</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.7768</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Commentary</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">367</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">367</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.7738" xmlns="http://purl.org/rss/1.0/"><title>Surgical response to the 2008 Mumbai terror attack</title><link>http://dx.doi.org/10.1002%2Fbjs.7738</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Surgical response to the 2008 Mumbai terror attack</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. H. Bhandarwar</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">G. D. Bakhshi</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. B. Tayade</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. D. Borisa</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">N. R. Thadeshwar</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. S. Gandhi</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.7738</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.7738</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.7738</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">368</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">372</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>Mumbai, the financial capital of India, was attacked by terrorists at various famous, densely populated places on 26 November 2008. The attack lasted for 60 h, resulting in multiple civilian casualties from bullet and blast injuries. The aim was to review the disaster management plan and analyse the injury patterns and surgical response.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>The disaster management plan was activated in the Sir Jamshetjee Jejeebhoy Group of Hospitals as soon as the earliest casualties were reported. The casualty receiving area was converted into a triage zone; patients were accordingly sent to different stations for further management. There was rotation of the duties of the medical personnel every 8 h for increased efficiency.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>A total of 271 casualties were encountered, of which 108 were dead at admission. Some 163 patients were triaged, 23 of whom received primary care as outpatients. The remaining 140 patients needed admission to hospital; 194 operations were performed in 127 patients. There were six postoperative deaths.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>This was a unique terrorist attack targeted on civilians and continuing for more than 2 days. The casualties consisted of military injuries due to combined firearm and blast trauma. Primary triage, or onsite triage once the site is safe, optimizes management. Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:Mumbai, the financial capital of India, was attacked by terrorists at various famous, densely populated places on 26 November 2008. The attack lasted for 60 h, resulting in multiple civilian casualties from bullet and blast injuries. The aim was to review the disaster management plan and analyse the injury patterns and surgical response.Methods:The disaster management plan was activated in the Sir Jamshetjee Jejeebhoy Group of Hospitals as soon as the earliest casualties were reported. The casualty receiving area was converted into a triage zone; patients were accordingly sent to different stations for further management. There was rotation of the duties of the medical personnel every 8 h for increased efficiency.Results:A total of 271 casualties were encountered, of which 108 were dead at admission. Some 163 patients were triaged, 23 of whom received primary care as outpatients. The remaining 140 patients needed admission to hospital; 194 operations were performed in 127 patients. There were six postoperative deaths.Conclusion:This was a unique terrorist attack targeted on civilians and continuing for more than 2 days. The casualties consisted of military injuries due to combined firearm and blast trauma. Primary triage, or onsite triage once the site is safe, optimizes management. Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.7824" xmlns="http://purl.org/rss/1.0/"><title>Risk factors for postoperative bleeding after thyroid surgery</title><link>http://dx.doi.org/10.1002%2Fbjs.7824</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Risk factors for postoperative bleeding after thyroid surgery</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">R. Promberger</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. Ott</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">F. Kober</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">C. Koppitsch</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">R. Seemann</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. Freissmuth</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. Hermann</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.7824</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.7824</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.7824</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">373</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">379</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>Postoperative bleeding after thyroid surgery is a feared and life-threatening complication. The aim of the study was to identify risk factors for postoperative bleeding, with special emphasis on the impact of the individual surgeon and the time to diagnosis of the complication.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>Data on consecutive thyroid operations were collected prospectively in a database over 30 years and analysed retrospectively for potential risk factors for postoperative bleeding.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>There were 30 142 operations and postoperative bleeding occurred in 519 patients (1·7 per cent). Risk factors identified were older age (odds ratio (OR) 1·03 per year), male sex (OR 1·64), extent of resection (OR up to 1·41), bilateral procedure (OR 1·99) and operation for recurrent disease (OR 1·54). The risk of complications among individual surgeons differed by up to sevenfold. Postoperative bleeding occurred in 336 (80·6 per cent) of 417 patients within the first 6 h after surgery. Postoperative bleeding was diagnosed after 24 h in ten patients (2·4 per cent), all of whom had bilateral procedures. Nine patients required urgent tracheostomy. Three patients died, giving a mortality rate of 0·01 per cent overall and 0·6 per cent among patients who had surgery for postoperative bleeding.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>Observation for up to 24 h is recommended for the majority of patients undergoing bilateral thyroid surgery in an endemic goitre area. Same-day discharge is feasible in selected patients, especially after a unilateral procedure. Quality improvement by continuous outcome monitoring and retraining of individual surgeons is suggested. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:Postoperative bleeding after thyroid surgery is a feared and life-threatening complication. The aim of the study was to identify risk factors for postoperative bleeding, with special emphasis on the impact of the individual surgeon and the time to diagnosis of the complication.Methods:Data on consecutive thyroid operations were collected prospectively in a database over 30 years and analysed retrospectively for potential risk factors for postoperative bleeding.Results:There were 30 142 operations and postoperative bleeding occurred in 519 patients (1·7 per cent). Risk factors identified were older age (odds ratio (OR) 1·03 per year), male sex (OR 1·64), extent of resection (OR up to 1·41), bilateral procedure (OR 1·99) and operation for recurrent disease (OR 1·54). The risk of complications among individual surgeons differed by up to sevenfold. Postoperative bleeding occurred in 336 (80·6 per cent) of 417 patients within the first 6 h after surgery. Postoperative bleeding was diagnosed after 24 h in ten patients (2·4 per cent), all of whom had bilateral procedures. Nine patients required urgent tracheostomy. Three patients died, giving a mortality rate of 0·01 per cent overall and 0·6 per cent among patients who had surgery for postoperative bleeding.Conclusion:Observation for up to 24 h is recommended for the majority of patients undergoing bilateral thyroid surgery in an endemic goitre area. Same-day discharge is feasible in selected patients, especially after a unilateral procedure. Quality improvement by continuous outcome monitoring and retraining of individual surgeons is suggested. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.8659" xmlns="http://purl.org/rss/1.0/"><title>Risk factors for postoperative bleeding after thyroid surgery (Br J Surg 2012; 99: 373–379)</title><link>http://dx.doi.org/10.1002%2Fbjs.8659</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Risk factors for postoperative bleeding after thyroid surgery (Br J Surg 2012; 99: 373–379)</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. Brauckhoff</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.8659</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.8659</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.8659</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Commentary</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">380</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">380</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.8666" xmlns="http://purl.org/rss/1.0/"><title>Impact of participation in randomized trials on outcome following surgery for gastro-oesophageal reflux</title><link>http://dx.doi.org/10.1002%2Fbjs.8666</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Impact of participation in randomized trials on outcome following surgery for gastro-oesophageal reflux</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">C. Engström</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">G. G. Jamieson</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">P. G. Devitt</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">T. Irvine</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">D. I. Watson</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.8666</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.8666</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.8666</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">381</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">386</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>Patients may be unwilling to participate in clinical trials if they perceive risks. Outcomes were evaluated following surgery for gastro-oesophageal reflux in patients recruited to randomized trials compared with patients not in trials.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>This study compared outcomes of patients who had surgery for reflux within or outside randomized trials between 1994 and 2009. The choice of procedure outside each trial was according to surgeon or patient preference. Clinical outcomes were determined 1 and 5 years after surgery using a standardized questionnaire, with analogue scales to assess heartburn, dysphagia and overall satisfaction. Subgroup analysis was undertaken for those aged less than 75 years undergoing laparoscopic Nissen fundoplication.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>Some 417 patients entered six randomized trials evaluating surgery for reflux and 981 underwent surgery outside the trials. The trial group contained a higher proportion of men and younger patients, and patients in trials were more likely to have undergone Nissen fundoplication. At 1 year, patients in the trials had slightly lower heartburn scores and less abdominal bloating, but otherwise similar outcomes to those not in the trials. At 5 years there were no differences, except for a slightly higher dysphagia score for liquids in the trial group. For the subgroup analysis, demographic data were similar for both groups. There were no differences at 1 year, but at 5 years patients enrolled in the trials had higher scores for dysphagia for liquids and heartburn. All of the statistically significant differences were thought unlikely to be clinically relevant.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>Participation in a randomized trial assessing surgery for reflux did not influence outcomes. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:Patients may be unwilling to participate in clinical trials if they perceive risks. Outcomes were evaluated following surgery for gastro-oesophageal reflux in patients recruited to randomized trials compared with patients not in trials.Methods:This study compared outcomes of patients who had surgery for reflux within or outside randomized trials between 1994 and 2009. The choice of procedure outside each trial was according to surgeon or patient preference. Clinical outcomes were determined 1 and 5 years after surgery using a standardized questionnaire, with analogue scales to assess heartburn, dysphagia and overall satisfaction. Subgroup analysis was undertaken for those aged less than 75 years undergoing laparoscopic Nissen fundoplication.Results:Some 417 patients entered six randomized trials evaluating surgery for reflux and 981 underwent surgery outside the trials. The trial group contained a higher proportion of men and younger patients, and patients in trials were more likely to have undergone Nissen fundoplication. At 1 year, patients in the trials had slightly lower heartburn scores and less abdominal bloating, but otherwise similar outcomes to those not in the trials. At 5 years there were no differences, except for a slightly higher dysphagia score for liquids in the trial group. For the subgroup analysis, demographic data were similar for both groups. There were no differences at 1 year, but at 5 years patients enrolled in the trials had higher scores for dysphagia for liquids and heartburn. All of the statistically significant differences were thought unlikely to be clinically relevant.Conclusion:Participation in a randomized trial assessing surgery for reflux did not influence outcomes. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.8658" xmlns="http://purl.org/rss/1.0/"><title>Role of the insulin-like growth factor 1 axis and visceral adiposity in oesophageal adenocarcinoma</title><link>http://dx.doi.org/10.1002%2Fbjs.8658</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Role of the insulin-like growth factor 1 axis and visceral adiposity in oesophageal adenocarcinoma</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">C. L. Donohoe</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. L. Doyle</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. McGarrigle</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. C. Cathcart</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">E. Daly</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. O'Grady</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. Lysaght</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">G. P. Pidgeon</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. V. Reynolds</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.8658</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.8658</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.8658</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">387</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">396</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>Epidemiological studies have linked obesity with many cancers. The insulin-like growth factor (IGF) 1 axis may be an important mediator in obesity-associated cancer. This study examined the relationship between IGF-1 and its receptor (IGF-1R) in oesophageal adenocarcinoma, a cancer strongly linked to obesity.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>Patients with oesophageal adenocarcinoma considered suitable for attempted curative treatment were studied. Visceral adiposity was defined by waist circumference or visceral fat area. Free and total IGF-1 in serum were measured by enzyme-linked immunosorbent assay. Quantitative polymerase chain resection was used to determine mRNA expression of IGF-1 and IGF-1R in resected tumour samples. IGF-1R expression in tissue microarrays (TMAs) was quantified by immunohistochemistry.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>A total of 220 patients were studied. Total and free IGF-1 levels were significantly increased in the serum of viscerally obese patients. Gene expression analysis revealed a significant association between obesity status and both IGF-1R (<em>P</em> = 0·021) and IGF-1 (<em>P</em> = 0·031) in tumours. TMA analysis demonstrated that IGF-1R expression in resected tumours was significantly higher in viscerally obese patients than in those of normal weight (<em>P</em> = 0·023). Disease-specific survival was longer in patients with negative IGF-1R expression than in those with IGF-1R-positive tumours (median 60·0 <em>versus</em> 23·4 months; <em>P</em> = 0·027).</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>This study highlighted the association of the IGF axis with visceral obesity, and a potential impact on the biology of oesophageal adenocarcinoma through its receptor. Targeting the IGF axis may have a rationale in future studies. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:Epidemiological studies have linked obesity with many cancers. The insulin-like growth factor (IGF) 1 axis may be an important mediator in obesity-associated cancer. This study examined the relationship between IGF-1 and its receptor (IGF-1R) in oesophageal adenocarcinoma, a cancer strongly linked to obesity.Methods:Patients with oesophageal adenocarcinoma considered suitable for attempted curative treatment were studied. Visceral adiposity was defined by waist circumference or visceral fat area. Free and total IGF-1 in serum were measured by enzyme-linked immunosorbent assay. Quantitative polymerase chain resection was used to determine mRNA expression of IGF-1 and IGF-1R in resected tumour samples. IGF-1R expression in tissue microarrays (TMAs) was quantified by immunohistochemistry.Results:A total of 220 patients were studied. Total and free IGF-1 levels were significantly increased in the serum of viscerally obese patients. Gene expression analysis revealed a significant association between obesity status and both IGF-1R (P = 0·021) and IGF-1 (P = 0·031) in tumours. TMA analysis demonstrated that IGF-1R expression in resected tumours was significantly higher in viscerally obese patients than in those of normal weight (P = 0·023). Disease-specific survival was longer in patients with negative IGF-1R expression than in those with IGF-1R-positive tumours (median 60·0 versus 23·4 months; P = 0·027).Conclusion:This study highlighted the association of the IGF axis with visceral obesity, and a potential impact on the biology of oesophageal adenocarcinoma through its receptor. Targeting the IGF axis may have a rationale in future studies. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.7812" xmlns="http://purl.org/rss/1.0/"><title>Prognostic significance of peritoneal washing cytology in patients with gastric cancer</title><link>http://dx.doi.org/10.1002%2Fbjs.7812</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Prognostic significance of peritoneal washing cytology in patients with gastric cancer</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. D. Lee</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">K. W. Ryu</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">B. W. Eom</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. H. Lee</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. C. Kook</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Y.-W. Kim</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.7812</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.7812</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.7812</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">397</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">403</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>Positive peritoneal washing cytology is a poor prognostic factor in patients with gastric cancer. The right therapeutic approach for this condition has not been well documented.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>Patients who underwent surgery for gastric cancer with suspected serosal invasion and peritoneal washing cytology at the Korean National Cancer Centre between May 2001 and December 2009 were included in this retrospective study. Clinicopathological factors and overall survival were analysed with respect to the cytological results and presence of peritoneal metastases. Prognostic factors were analysed in patients with positive cytology but without overt peritoneal metastases.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>A total of 1072 patients were included in the analysis, of whom 900 had negative cytology (C0 group) and 172 had positive cytology (C1 group). No peritoneal metastases (P0) were found in 830 patients (92·2 per cent) in the C0 group. Peritoneal metastases (P1) were found in 76 patients (44·2 per cent) in the C1 group. Median overall survival times in the P0 C1, P1 C0 and P1 C1 subgroups were 20·0, 14·0 and 10·0 months respectively. Multivariable analysis of the P0 C1 subgroup revealed that clinical N0–2 category and gastric resection were significantly associated with better prognosis (median survival 24·0 <em>versus</em> 13·0 months for N0–2 <em>versus</em> N3, and 21·0 <em>versus</em> 4·0 months for resected <em>versus</em> non-resected).</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>Positive washing cytology in patients with gastric cancer is a negative prognostic factor for patients with, as well as those without, overt peritoneal metastases. Resection is an option in patients with clinical stage N0–2 disease without peritoneal metastases but with a positive washing cytology finding. Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:Positive peritoneal washing cytology is a poor prognostic factor in patients with gastric cancer. The right therapeutic approach for this condition has not been well documented.Methods:Patients who underwent surgery for gastric cancer with suspected serosal invasion and peritoneal washing cytology at the Korean National Cancer Centre between May 2001 and December 2009 were included in this retrospective study. Clinicopathological factors and overall survival were analysed with respect to the cytological results and presence of peritoneal metastases. Prognostic factors were analysed in patients with positive cytology but without overt peritoneal metastases.Results:A total of 1072 patients were included in the analysis, of whom 900 had negative cytology (C0 group) and 172 had positive cytology (C1 group). No peritoneal metastases (P0) were found in 830 patients (92·2 per cent) in the C0 group. Peritoneal metastases (P1) were found in 76 patients (44·2 per cent) in the C1 group. Median overall survival times in the P0 C1, P1 C0 and P1 C1 subgroups were 20·0, 14·0 and 10·0 months respectively. Multivariable analysis of the P0 C1 subgroup revealed that clinical N0–2 category and gastric resection were significantly associated with better prognosis (median survival 24·0 versus 13·0 months for N0–2 versus N3, and 21·0 versus 4·0 months for resected versus non-resected).Conclusion:Positive washing cytology in patients with gastric cancer is a negative prognostic factor for patients with, as well as those without, overt peritoneal metastases. Resection is an option in patients with clinical stage N0–2 disease without peritoneal metastases but with a positive washing cytology finding. Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.8664" xmlns="http://purl.org/rss/1.0/"><title>Impact of nationwide centralization of pancreaticoduodenectomy on hospital mortality </title><link>http://dx.doi.org/10.1002%2Fbjs.8664</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Impact of nationwide centralization of pancreaticoduodenectomy on hospital mortality </dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">R. F. de Wilde</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. G. H. Besselink</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">I. van der Tweel</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">I. H. J. T. de Hingh</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">C. H. J. van Eijck</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">C. H. C. Dejong</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">R. J. Porte</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">D. J. Gouma</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">O. R. C. Busch</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">I. Q. Molenaar</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.8664</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.8664</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.8664</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">404</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">410</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>The impact of nationwide centralization of pancreaticoduodenectomy (PD) on mortality is largely unknown. The aim of this study was to analyse changes in hospital volumes and in-hospital mortality after PD in the Netherlands between 2004 and 2009.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>Nationwide data on International Classification of Diseases, ninth revision (ICD-9) code 5-526 (PD, including Whipple), patient age, sex and mortality were retrieved from the independent nationwide KiwaPrismant registry. Based on established cut-off points of annually performed PDs, hospitals were categorized as very low (fewer than 5), low (5–10), medium (11–19) or high (at least 20) volume. A subgroup analysis based on a cut-off age of 70 years was also performed.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>Some 2155 PDs were included. The number of hospitals performing PD decreased from 48 in 2004 to 30 in 2009 (<em>P</em> = 0·011). In these specific years, the proportion of patients undergoing PD in a medium- or high-volume centre increased from 52·9 to 91·2 per cent (<em>P</em> &lt; 0·001). Nationwide mortality rates after PD decreased from 9·8 to 5·1 per cent (<em>P</em> = 0·044). The mortality rate during the 6-year period was 14·7, 9·8, 6·3 and 3·3 per cent in very low-, low-, medium- and high-volume hospitals respectively (<em>P</em> &lt; 0·001). The difference in mortality between medium- and high-volume centres was statistically significant (<em>P</em> = 0·004). The volume–outcome relationship was not influenced by age (<em>P</em> = 0·467). The mortality rate after PD in patients aged at least 70 years was 10·4 per cent compared with 4·4 per cent in younger patients (<em>P</em> &lt; 0·001).</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>With nationwide centralization of PD, the in-hospital mortality rate after this procedure decreased. Further centralization of PD is likely to decrease mortality further, especially in the elderly. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:The impact of nationwide centralization of pancreaticoduodenectomy (PD) on mortality is largely unknown. The aim of this study was to analyse changes in hospital volumes and in-hospital mortality after PD in the Netherlands between 2004 and 2009.Methods:Nationwide data on International Classification of Diseases, ninth revision (ICD-9) code 5-526 (PD, including Whipple), patient age, sex and mortality were retrieved from the independent nationwide KiwaPrismant registry. Based on established cut-off points of annually performed PDs, hospitals were categorized as very low (fewer than 5), low (5–10), medium (11–19) or high (at least 20) volume. A subgroup analysis based on a cut-off age of 70 years was also performed.Results:Some 2155 PDs were included. The number of hospitals performing PD decreased from 48 in 2004 to 30 in 2009 (P = 0·011). In these specific years, the proportion of patients undergoing PD in a medium- or high-volume centre increased from 52·9 to 91·2 per cent (P &lt; 0·001). Nationwide mortality rates after PD decreased from 9·8 to 5·1 per cent (P = 0·044). The mortality rate during the 6-year period was 14·7, 9·8, 6·3 and 3·3 per cent in very low-, low-, medium- and high-volume hospitals respectively (P &lt; 0·001). The difference in mortality between medium- and high-volume centres was statistically significant (P = 0·004). The volume–outcome relationship was not influenced by age (P = 0·467). The mortality rate after PD in patients aged at least 70 years was 10·4 per cent compared with 4·4 per cent in younger patients (P &lt; 0·001).Conclusion:With nationwide centralization of PD, the in-hospital mortality rate after this procedure decreased. Further centralization of PD is likely to decrease mortality further, especially in the elderly. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.7821" xmlns="http://purl.org/rss/1.0/"><title>Prospective surveillance study of the management of intussusception in UK and Irish infants </title><link>http://dx.doi.org/10.1002%2Fbjs.7821</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Prospective surveillance study of the management of intussusception in UK and Irish infants </dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">L. Samad</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. Marven</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">H. El Bashir</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. G. Sutcliffe</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. C. Cameron</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">R. Lynn</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">B. Taylor</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.7821</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.7821</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.7821</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">411</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">415</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>Intussusception is the most common cause of acute intestinal obstruction in infants. This study examined the clinical presentation, management and outcomes of intussusception in this age group.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>Prospective surveillance of intussusception in infants was carried out between March 2008 and March 2009 in the UK and Ireland. Monthly cards were sent to paediatric clinicians who were requested to notify cases of intussusception.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>The study identified 261 confirmed cases. The commonest presenting symptom/sign was non-bilious vomiting, in 210 (80·5 per cent) of the infants. Abdominal ultrasonography was done in 247 infants (94·6 per cent) and was diagnostic in 242 (98·0 per cent), compared with plain abdominal X-ray, which was diagnostic in 33 (23·6 per cent) of 140 infants. Enema reduction was carried out in 240 (92·0 per cent) of the 261 infants; the majority (237, 98·8 per cent) had pneumatic reduction with a success rate of 61·2 per cent (145 of 237). Surgery was required in 111 infants (42·5 per cent); 92 operations were as a result of unsuccessful enema reduction, and the remaining 19 infants (17·1 per cent) had primary surgery. Forty-four infants (39·6 per cent of operations) needed a bowel resection. The majority of children (238, 91·2 per cent) recovered uneventfully; 21 (8·0 per cent) had sequelae, one child died (0·4 per cent), and the outcome was unknown for one infant.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>This study described current treatment patterns for intussusception in infancy; these represent a benchmark for improved standards of care for this condition. Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:Intussusception is the most common cause of acute intestinal obstruction in infants. This study examined the clinical presentation, management and outcomes of intussusception in this age group.Methods:Prospective surveillance of intussusception in infants was carried out between March 2008 and March 2009 in the UK and Ireland. Monthly cards were sent to paediatric clinicians who were requested to notify cases of intussusception.Results:The study identified 261 confirmed cases. The commonest presenting symptom/sign was non-bilious vomiting, in 210 (80·5 per cent) of the infants. Abdominal ultrasonography was done in 247 infants (94·6 per cent) and was diagnostic in 242 (98·0 per cent), compared with plain abdominal X-ray, which was diagnostic in 33 (23·6 per cent) of 140 infants. Enema reduction was carried out in 240 (92·0 per cent) of the 261 infants; the majority (237, 98·8 per cent) had pneumatic reduction with a success rate of 61·2 per cent (145 of 237). Surgery was required in 111 infants (42·5 per cent); 92 operations were as a result of unsuccessful enema reduction, and the remaining 19 infants (17·1 per cent) had primary surgery. Forty-four infants (39·6 per cent of operations) needed a bowel resection. The majority of children (238, 91·2 per cent) recovered uneventfully; 21 (8·0 per cent) had sequelae, one child died (0·4 per cent), and the outcome was unknown for one infant.Conclusion:This study described current treatment patterns for intussusception in infancy; these represent a benchmark for improved standards of care for this condition. Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.7837" xmlns="http://purl.org/rss/1.0/"><title>Predictive factors for postoperative constipation and continence after stapled transanal rectal resection</title><link>http://dx.doi.org/10.1002%2Fbjs.7837</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Predictive factors for postoperative constipation and continence after stapled transanal rectal resection</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">L. Boenicke</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. Reibetanz</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. Kim</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">N. Schlegel</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">C.-T. Germer</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">C. Isbert</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.7837</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.7837</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.7837</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">416</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">422</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>Although stapled transanal rectal resection (STARR) has become an important surgical option in the treatment of obstructive defaecation syndrome, objective data about parameters that predict its success or failure are not yet available.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>Medical history, clinical and radiomorphological data were obtained prospectively from a multi-institutional STARR registry. Predictive factors for postoperative constipation (Cleveland Clinic Constipation Score, CCS) and incontinence (Cleveland Clinic Incontinence Score, CCIS) were identified using univariable and multivariable analysis.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>Data were obtained for 181 of 201 patients in the STARR registry, with completed median follow-up of 19·4 (range 12–41) months. Although the CCS decreased significantly overall (from mean(s.d.) 16·3(4·9) to 6·7(4·1); <em>P</em> &lt; 0·001), 31 patients (17·1 per cent) complained about persisting constipation. CCIS levels remained unchanged overall, but 16 patients (8·8 per cent) had new-onset faecal incontinence. Multivariable analysis revealed that rectocele (β = − 0·302, <em>P</em> &lt; 0·001) and intussusception (β = − 0·392, <em>P</em> &lt; 0·001) were independent predictors of low CCS levels, and intussusception (β = − 0·216, <em>P</em> = 0·001) and enterocele (β = − 0·171, <em>P</em> = 0·012) were independent predictors of low CCIS levels. In contrast, small rectal diameter (β = − 0·293, <em>P</em> &lt; 0·001), low squeeze pressure (β = − 0·188, <em>P</em> = 0·005) and increased pelvic floor descent at rest (β = 0·264, <em>P</em> &lt; 0·001) predicted high CCIS levels.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>Factors for a favourable outcome after STARR included rectocele, intussusception and enterocele, whereas small rectal diameter, low sphincter pressure and increased pelvic floor descent were unfavourable. These findings should be integrated into the therapy algorithm for STARR. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:Although stapled transanal rectal resection (STARR) has become an important surgical option in the treatment of obstructive defaecation syndrome, objective data about parameters that predict its success or failure are not yet available.Methods:Medical history, clinical and radiomorphological data were obtained prospectively from a multi-institutional STARR registry. Predictive factors for postoperative constipation (Cleveland Clinic Constipation Score, CCS) and incontinence (Cleveland Clinic Incontinence Score, CCIS) were identified using univariable and multivariable analysis.Results:Data were obtained for 181 of 201 patients in the STARR registry, with completed median follow-up of 19·4 (range 12–41) months. Although the CCS decreased significantly overall (from mean(s.d.) 16·3(4·9) to 6·7(4·1); P &lt; 0·001), 31 patients (17·1 per cent) complained about persisting constipation. CCIS levels remained unchanged overall, but 16 patients (8·8 per cent) had new-onset faecal incontinence. Multivariable analysis revealed that rectocele (β = − 0·302, P &lt; 0·001) and intussusception (β = − 0·392, P &lt; 0·001) were independent predictors of low CCS levels, and intussusception (β = − 0·216, P = 0·001) and enterocele (β = − 0·171, P = 0·012) were independent predictors of low CCIS levels. In contrast, small rectal diameter (β = − 0·293, P &lt; 0·001), low squeeze pressure (β = − 0·188, P = 0·005) and increased pelvic floor descent at rest (β = 0·264, P &lt; 0·001) predicted high CCIS levels.Conclusion:Factors for a favourable outcome after STARR included rectocele, intussusception and enterocele, whereas small rectal diameter, low sphincter pressure and increased pelvic floor descent were unfavourable. These findings should be integrated into the therapy algorithm for STARR. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.7817" xmlns="http://purl.org/rss/1.0/"><title>Postoperative adhesion prevention using a statin-containing cellulose film in an experimental model</title><link>http://dx.doi.org/10.1002%2Fbjs.7817</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Postoperative adhesion prevention using a statin-containing cellulose film in an experimental model</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. Lalountas</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">K. D. Ballas</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. Michalakis</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">K. Psarras</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">C. Asteriou</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">D. E. Giakoustidis</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">C. Nikolaidou</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">I. Venizelos</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">T. E. Pavlidis</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. K. Sakantamis</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.7817</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.7817</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.7817</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">423</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">429</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>Intraperitoneal adhesions are a common problem in abdominal surgery. The aim of this study was to compare the effectiveness of Statofilm, a novel antiadhesive film based on cross-linked carboxymethylcellulose and atorvastatin, with that of sodium hyaluronate–carboxymethylcellulose (Seprafilm<sup>®</sup>) in the prevention of postoperative intraperitoneal adhesions in rats.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>One hundred male Wistar rats underwent a laparotomy and adhesions were induced by caecal abrasion. The animals were allocated to five groups: a control group with no adhesion barrier, Seprafilm<sup>®</sup> group, placebo group with a film containing carboxymethylcellulose without atorvastatin, and low- and high-dose groups with films containing carboxymethylcellulose and atorvastatin 0·125 and 1 mg per kg bodyweight respectively. Adhesions were classified by two independent surgeons 2 weeks after surgery. Caecal biopsies were obtained for histological evaluation of fibrosis, inflammation and vascular proliferation.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>All antiadhesive film groups (Seprafilm<sup>®</sup>, placebo, low-dose and high-dose) had statistically significant adhesion reduction compared with the control group (<em>P</em> &lt; 0·001, <em>P</em> = 0·015, <em>P</em> &lt; 0·001 and <em>P</em> &lt; 0·001 respectively). The low-dose Statofilm was superior to Seprafilm<sup>®</sup> in terms of adhesion prevention (<em>P</em> = 0·001). Adhesions were present in three-quarters of rats in the Seprafilm<sup>®</sup> group, but only one-quarter in the low-dose Statofilm group.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>The data suggest that the newly developed adhesion barrier Statofilm has better results than Seprafilm<sup>®</sup> in preventing postoperative adhesions in rats. A low-dose atorvastatin-containing film, such as Statofilm, could be evaluated for future clinical application. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:Intraperitoneal adhesions are a common problem in abdominal surgery. The aim of this study was to compare the effectiveness of Statofilm, a novel antiadhesive film based on cross-linked carboxymethylcellulose and atorvastatin, with that of sodium hyaluronate–carboxymethylcellulose (Seprafilm®) in the prevention of postoperative intraperitoneal adhesions in rats.Methods:One hundred male Wistar rats underwent a laparotomy and adhesions were induced by caecal abrasion. The animals were allocated to five groups: a control group with no adhesion barrier, Seprafilm® group, placebo group with a film containing carboxymethylcellulose without atorvastatin, and low- and high-dose groups with films containing carboxymethylcellulose and atorvastatin 0·125 and 1 mg per kg bodyweight respectively. Adhesions were classified by two independent surgeons 2 weeks after surgery. Caecal biopsies were obtained for histological evaluation of fibrosis, inflammation and vascular proliferation.Results:All antiadhesive film groups (Seprafilm®, placebo, low-dose and high-dose) had statistically significant adhesion reduction compared with the control group (P &lt; 0·001, P = 0·015, P &lt; 0·001 and P &lt; 0·001 respectively). The low-dose Statofilm was superior to Seprafilm® in terms of adhesion prevention (P = 0·001). Adhesions were present in three-quarters of rats in the Seprafilm® group, but only one-quarter in the low-dose Statofilm group.Conclusion:The data suggest that the newly developed adhesion barrier Statofilm has better results than Seprafilm® in preventing postoperative adhesions in rats. A low-dose atorvastatin-containing film, such as Statofilm, could be evaluated for future clinical application. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.7814" xmlns="http://purl.org/rss/1.0/"><title>Postoperative adhesion prevention using a statin-containing cellulose film in an experimental model (Br J Surg 2012; 99: 423–429)</title><link>http://dx.doi.org/10.1002%2Fbjs.7814</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Postoperative adhesion prevention using a statin-containing cellulose film in an experimental model (Br J Surg 2012; 99: 423–429)</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. H. F. Schreinemacher</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.7814</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.7814</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.7814</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Commentary</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">430</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">430</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.7832" xmlns="http://purl.org/rss/1.0/"><title>Case-matched analysis of outcome after open retropubic radical prostatectomy in patients with previous preperitoneal inguinal hernia repair</title><link>http://dx.doi.org/10.1002%2Fbjs.7832</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Case-matched analysis of outcome after open retropubic radical prostatectomy in patients with previous preperitoneal inguinal hernia repair</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">E. Peeters</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">S. Joniau</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">H. Van Poppel</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. Miserez</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.7832</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.7832</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.7832</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">431</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">435</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>The impact of preperitoneal mesh repair for inguinal hernia on future pelvic surgery is debatable. This retrospective study investigated the impact of previous preperitoneal inguinal hernia repair (PIHR) on outcome after open retropubic radical prostatectomy (RRP) for prostatic cancer.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>Patients who had open RRP and who had previously undergone PIHR were identified. They were compared with a control group of patients matched for age, body mass index and tumour risk profile who had no history of inguinal hernia repair. Outcome measures included intraoperative data, histopathology and results at follow-up.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>Sixty patients who had undergone open RRP after a previous PIHR were compared with 60 control patients. Operations lasted longer in the PIHR group (median (interquartile range, i.q.r.) 100 (90–120) <em>versus</em> 90 (85–100) min respectively; <em>P</em> &lt; 0·001) and the operation was assessed as more difficult by the surgeon (<em>P</em> = 0·022). Hospital stay was longer for patients who had undergone PIHR (median (i.q.r.) 7 (6–9) <em>versus</em> 6 (5–7) days; <em>P</em> = 0·012) and urinary catheterization was prolonged (13 (11–14) <em>versus</em> 11 (11–12) days; <em>P</em> = 0·006). Among patients with intermediate- and high-risk disease, fewer lymph nodes were excised in the PIHR group than in the control group (median (i.q.r.) 2 (0–7) <em>versus</em> 8 (5–12) nodes; <em>P</em> &lt; 0·001).</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>Open RRP for prostatic cancer was more difficult to perform after previous PIHR, and was associated with a longer hospital stay and less adequate lymphadenectomy for intermediate- and high-risk prostatic cancer. Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:The impact of preperitoneal mesh repair for inguinal hernia on future pelvic surgery is debatable. This retrospective study investigated the impact of previous preperitoneal inguinal hernia repair (PIHR) on outcome after open retropubic radical prostatectomy (RRP) for prostatic cancer.Methods:Patients who had open RRP and who had previously undergone PIHR were identified. They were compared with a control group of patients matched for age, body mass index and tumour risk profile who had no history of inguinal hernia repair. Outcome measures included intraoperative data, histopathology and results at follow-up.Results:Sixty patients who had undergone open RRP after a previous PIHR were compared with 60 control patients. Operations lasted longer in the PIHR group (median (interquartile range, i.q.r.) 100 (90–120) versus 90 (85–100) min respectively; P &lt; 0·001) and the operation was assessed as more difficult by the surgeon (P = 0·022). Hospital stay was longer for patients who had undergone PIHR (median (i.q.r.) 7 (6–9) versus 6 (5–7) days; P = 0·012) and urinary catheterization was prolonged (13 (11–14) versus 11 (11–12) days; P = 0·006). Among patients with intermediate- and high-risk disease, fewer lymph nodes were excised in the PIHR group than in the control group (median (i.q.r.) 2 (0–7) versus 8 (5–12) nodes; P &lt; 0·001).Conclusion:Open RRP for prostatic cancer was more difficult to perform after previous PIHR, and was associated with a longer hospital stay and less adequate lymphadenectomy for intermediate- and high-risk prostatic cancer. Copyright © 2011 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.7816" xmlns="http://purl.org/rss/1.0/"><title>Comprehensive national analysis of emergency and essential surgical capacity in Rwanda</title><link>http://dx.doi.org/10.1002%2Fbjs.7816</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Comprehensive national analysis of emergency and essential surgical capacity in Rwanda</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">R. T. Petroze</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. Nzayisenga</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">V. Rusanganwa</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">G. Ntakiyiruta</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">J. F. Calland</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.7816</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.7816</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.7816</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">436</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">443</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="section" id="abs1-1" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Background:</h3><div class="para"><p>Disparities in the global availability of operating theatres, essential surgical equipment and surgically trained providers are profound. Although efforts are ongoing to increase surgical care and training, little is known about the surgical capacity in developing countries. The aim of this study was to create a baseline for surgical development planning at a national level.</p></div></div><div class="section" id="abs1-2" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Methods:</h3><div class="para"><p>A locally adapted World Health Organization survey was conducted in November 2010 to assess emergency and essential surgical capacity and volumes, with on-site interviews at 44 district and referral hospitals in Rwanda. Results were compiled for education and capacity development discussions with the Rwandan Ministry of Health and the Rwanda Surgical Society.</p></div></div><div class="section" id="abs1-3" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Results:</h3><div class="para"><p>Among 10·1 million people, there were 44 hospitals and 124 operating rooms (1·2 operating rooms per 100 000 persons). There was a total of 50 surgeons practising full- or part-time in Rwanda (0·49 total surgeons per 100 000 persons). The majority of consultant surgeons worked in the capital (covering 10 per cent of the population). Anaesthesia was performed primarily by anaesthesia technicians, and six of 44 hospitals had no trained anaesthesia provider. Continuous availability of electricity, running water and generators was lacking in eight hospitals, and 19 reported an absence or shortage in the availability of pulse oximetry. Equipment for life-saving surgical airway procedures, particularly in children, was lacking. A dedicated emergency area was available in only 19 hospitals. In 2009 and 2010 over 80 000 surgical procedures (major and minor) were recorded annually in Rwanda.</p></div></div><div class="section" id="abs1-4" xmlns="http://www.w3.org/1999/xhtml"><h3 xhtml="http://www.w3.org/1999/xhtml" xmlns="http://purl.org/rss/1.0/">Conclusion:</h3><div class="para"><p>A comprehensive countrywide assessment of surgical capacity in resource-limited settings found severe shortages in available resources. Immediate local feedback is a useful tool for creating a baseline of surgical capacity to inform country-specific surgical development. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div></div>]]></content:encoded><description>Background:Disparities in the global availability of operating theatres, essential surgical equipment and surgically trained providers are profound. Although efforts are ongoing to increase surgical care and training, little is known about the surgical capacity in developing countries. The aim of this study was to create a baseline for surgical development planning at a national level.Methods:A locally adapted World Health Organization survey was conducted in November 2010 to assess emergency and essential surgical capacity and volumes, with on-site interviews at 44 district and referral hospitals in Rwanda. Results were compiled for education and capacity development discussions with the Rwandan Ministry of Health and the Rwanda Surgical Society.Results:Among 10·1 million people, there were 44 hospitals and 124 operating rooms (1·2 operating rooms per 100 000 persons). There was a total of 50 surgeons practising full- or part-time in Rwanda (0·49 total surgeons per 100 000 persons). The majority of consultant surgeons worked in the capital (covering 10 per cent of the population). Anaesthesia was performed primarily by anaesthesia technicians, and six of 44 hospitals had no trained anaesthesia provider. Continuous availability of electricity, running water and generators was lacking in eight hospitals, and 19 reported an absence or shortage in the availability of pulse oximetry. Equipment for life-saving surgical airway procedures, particularly in children, was lacking. A dedicated emergency area was available in only 19 hospitals. In 2009 and 2010 over 80 000 surgical procedures (major and minor) were recorded annually in Rwanda.Conclusion:A comprehensive countrywide assessment of surgical capacity in resource-limited settings found severe shortages in available resources. Immediate local feedback is a useful tool for creating a baseline of surgical capacity to inform country-specific surgical development. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.7815" xmlns="http://purl.org/rss/1.0/"><title>Comprehensive national analysis of emergency and essential surgical capacity in Rwanda (Br J Surg 2012: 99: 436–443)</title><link>http://dx.doi.org/10.1002%2Fbjs.7815</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Comprehensive national analysis of emergency and essential surgical capacity in Rwanda (Br J Surg 2012: 99: 436–443)</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. Gawande</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.7815</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.7815</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.7815</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Commentary</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">444</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">444</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.8680" xmlns="http://purl.org/rss/1.0/"><title>Importance of specimen length during temporal artery biopsy (Br J Surg 2011; 98: 1556–1560)</title><link>http://dx.doi.org/10.1002%2Fbjs.8680</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Importance of specimen length during temporal artery biopsy (Br J Surg 2011; 98: 1556–1560)</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">L. Rohman</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. W. Phillips</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.8680</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.8680</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.8680</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Your Views</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">445</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">445</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3><div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>The Editors welcome topical correspondence from readers relating to articles published in the Journal. Responses should be sent electronically via the <em>BJS</em> website (<!--TODO: clickthrough URL--><a href="http://www.bjs.co.uk" title="Link to external resource: http://www.bjs.co.uk">www.bjs.co.uk</a>). All letters will be reviewed and, if approved, appear on the website. A selection of these will be edited and published in the Journal. Letters must be no more than 250 words in length. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</p></div>]]></content:encoded><description>The Editors welcome topical correspondence from readers relating to articles published in the Journal. Responses should be sent electronically via the BJS website (www.bjs.co.uk). All letters will be reviewed and, if approved, appear on the website. A selection of these will be edited and published in the Journal. Letters must be no more than 250 words in length. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley &amp; Sons, Ltd.</description></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.8681" xmlns="http://purl.org/rss/1.0/"><title>Author's reply: Importance of specimen length during temporal artery biopsy (Br J Surg 2011; 98: 1556–1560)</title><link>http://dx.doi.org/10.1002%2Fbjs.8681</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Author's reply: Importance of specimen length during temporal artery biopsy (Br J Surg 2011; 98: 1556–1560)</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">E. Ypsilantis</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.8681</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.8681</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.8681</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Your Views</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">445</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">445</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.8682" xmlns="http://purl.org/rss/1.0/"><title>Systematic review and meta-analysis of the use of lightweight versus heavyweight mesh in open inguinal hernia repair (Br J Surg 2012; 99: 29–37)</title><link>http://dx.doi.org/10.1002%2Fbjs.8682</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Systematic review and meta-analysis of the use of lightweight versus heavyweight mesh in open inguinal hernia repair (Br J Surg 2012; 99: 29–37)</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">N. Ashraf</dc:creator><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. Uzzaman</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.8682</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.8682</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.8682</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Your Views</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">446</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">446</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.8683" xmlns="http://purl.org/rss/1.0/"><title>Author's reply: Systematic review and meta-analysis of the use of lightweight versus heavyweight mesh in open inguinal hernia repair (Br J Surg 2012; 99: 29–37)</title><link>http://dx.doi.org/10.1002%2Fbjs.8683</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Author's reply: Systematic review and meta-analysis of the use of lightweight versus heavyweight mesh in open inguinal hernia repair (Br J Surg 2012; 99: 29–37)</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">M. S. Sajid</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.8683</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.8683</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.8683</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Your Views</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">446</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">446</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://dx.doi.org/10.1002%2Fbjs.8694" xmlns="http://purl.org/rss/1.0/"><title>Scientific Surgery</title><link>http://dx.doi.org/10.1002%2Fbjs.8694</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Scientific Surgery</dc:title><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-03-01T00:00:00-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1002/bjs.8694</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1002/bjs.8694</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://dx.doi.org/10.1002%2Fbjs.8694</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Scientific Surgery</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">447</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">447</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item></rdf:RDF>
